Hypothyroidism, levothyroxine purchases

HYPOTHY_LEVOTHY

hypothyroidism: Abnormally low levels of thyroid hormone.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — H03AA01 1 out of 7 registries used, show all original rules.	65497
4. Check minimum number of events Min. number of events 3	65497
5. Include endpoints None	65497
6. Filter based on genotype QC (FinnGen only)	65497

Control definitions (FinnGen only)

Control exclude: E4_MALNUTRITION, E4_DIABETES, I9_CVD, C3_CANCER, MENINGITIS, ENCEPHALITIS, HYPOTHYROIDISM, D3_ANAEMIA, F5_ALLANXIOUS, F5_MOOD, F5_SCHIZO, F5_BEHEMOCHILD, F5_UNSMENDIS, ANOSMIA, ANTIDEPRESSANTS

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	HYPOTHY_LEVOTHY
CONTROL_EXCLUDE	E4_MALNUTRITION\|E4_DIABETES\|I9_CVD\|C3_CANCER\|MENINGITIS\|ENCEPHALITIS\|HYPOTHYROIDISM\|D3_ANAEMIA\|F5_ALLANXIOUS\|F5_MOOD\|F5_SCHIZO\|F5_BEHEMOCHILD\|F5_UNSMENDIS\|ANOSMIA\|ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	H03AA01
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypothyroidism, levothyroxine purchases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	65497	52436	13061
Unadjusted period prevalence (%)	15.46	17.87	5.76
Median age at first event (years)	52.76	50.95	60.03

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4309: Matched controls
35017

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N05AH03

ATC

olanzapine; systemic

383.7

323.0

389

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

681.6

323.0

383

E03

ICD-10 Finland

Other hypothyroidism

183.9

323.0

702

N06AX16

ATC

venlafaxine; oral

71.3

323.0

695

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

323.0

423

103

Kela drug reimbursment

Diabetes, insulin-treated

7553.3

323.0

775

N06AB06

ATC

sertraline; oral

34.6

323.0

519

138

N06AX12

ATC

bupropion; oral

76.8

323.0

434

N06AB03

ATC

fluoxetine; oral

38.7

323.0

469

110

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

84.6

323.0

423

N06AB04

ATC

citalopram; systemic

23.7

323.0

671

270

E03.89

ICD-10 Finland

Other specified hypothyroidism

266.2

323.0

386

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

482.4

323.0

524

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

30.3

323.0

524

159

T90

ICPC

Diabetes non-insulin dependent

40.8

323.0

447

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

90.2

323.0

430

104

Kela drug reimbursment

Thyroid insufficiency

+∞

323.0

785

A10BA02

ATC

metformin; oral

45.3

323.0

586

121

N06AX11

ATC

mirtazapine; oral

8.4

323.0

1190

1517

215

Kela drug reimbursment

Diabetes, non-insulin-treated

7469.7

323.0

768

C07AB07

ATC

bisoprolol; oral

8.7

323.0

896

1022

A10AE04

ATC

insulin glargine; parenteral

1672.1

323.0

393

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1166.7

323.0

392

N06AB10

ATC

escitalopram; oral

18.5

323.0

991

556

N05AH04

ATC

quetiapine; oral

25.4

323.0

1007

416

T86

ICPC

Hypothyroidism/myxoedema

372.5

323.0

527

H03AA01

ATC

levothyroxine sodium; systemic

+∞

323.0

4309

146

F32.9

ICD-10 Finland

Depressive episode, unspecified

24.9

323.0

767

302

N05BA04

ATC

oxazepam; oral

11.2

323.0

838

741

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

424.8

323.0

1649

BAA60

NOMESCO Finland

Total thyroidectomy

486.9

312.8

333

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

13.6

311.5

591

404

SPAT1262

SPAT

Handing over of treatment supplies

14.9

303.6

553

342

N05AX08

ATC

risperidone; systemic

106.6

299.7

350

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

9.5

298.2

684

685

N05AX12

ATC

aripiprazole; systemic

348.8

296.9

320

T89

ICPC

Diabetes insulin dependent

665.3

288.8

305

205

Kela drug reimbursment

Chronic hypertension

+∞

285.3

293

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

118.9

281.2

325

A10AE05

ATC

insulin detemir; parenteral

+∞

278.4

286

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

145.4

264.0

300

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

301.7

257.8

280

N06AX26

ATC

vortioxetine; oral

52.2

254.3

327

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

8.5

250.0

607

660

N06AX21

ATC

duloxetine; oral

28.2

249.4

366

115

H04AA01

ATC

glucagon; nasal, parenteral

757.4

249.4

263

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2143.0

247.4

257

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

+∞

245.9

253

N05CF01

ATC

zopiclone; oral

5.7

243.7

800

1336

C07AA05

ATC

propranolol; systemic

5.5

232.3

793

1382

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.8

225.5

1182

3160

N03AX09

ATC

lamotrigine; oral

28.7

224.0

327

100

F29

ICD-10 Finland

Unspecified nonorganic psychosis

501.1

219.3

234

H03BB01

ATC

carbimazole; oral

30.2

213.8

308

N05AA02

ATC

levomepromazine; systemic

313.3

203.5

221

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

+∞

199.7

206

I10

ICD-10 Finland

Essential (primary) hypertension

4.1

198.1

914

2151

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

435.6

191.1

205

P76

ICPC

Depressive disorder

13.6

188.6

355

230

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.7

187.0

606

975

N05AN01

ATC

lithium; oral

340.6

185.6

201

A02BC02

ATC

pantoprazole; systemic

2.7

185.4

1883

7813

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

419.9

184.3

198

C03CA01

ATC

furosemide; systemic

24.2

182.5

279

100

N03AG01

ATC

valproic acid; systemic, rectal

14.4

180.9

332

202

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

29.0

180.2

262

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

6.8

180.0

503

664

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

8.6

179.0

428

444

A10AE06

ATC

insulin degludec; parenteral

+∞

178.2

184

T36

ICD-10 Finland

Poisoning by systemic antibiotics

25.2

170.2

257

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

258.9

165.8

182

A10AA02

ATC

1522.8

165.3

173

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

71.4

163.9

201

A10AA01

ATC

1481.2

161.4

169

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

160.6

166

C10AA01

ATC

simvastatin; oral

5.0

157.5

573

1043

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

7.1

154.2

416

518

N05BA01

ATC

diazepam; systemic, rectal

6.7

154.1

436

581

C10AA05

ATC

atorvastatin; oral

4.5

153.9

621

1259

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

152.8

158

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

34.8

152.4

212

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

22.2

152.0

238

G47.3

ICD-10 Finland

Sleep apnoea

3.6

151.8

822

2169

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

1378.4

151.7

159

N02BE01

ATC

paracetamol; systemic, rectal

2.4

148.6

3051

17559

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

92.6

147.3

175

A10BK03

ATC

empagliflozin; oral

439.7

146.2

157

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

8.7

145.9

345

348

E11

ICD-10 Finland

Type 2 diabetes mellitus

18.9

143.1

236

107

C08CA01

ATC

amlodipine; oral

4.9

142.9

529

976

F41.1

ICD-10 Finland

Generalized anxiety disorder

11.7

142.3

286

212

E10

ICD-10 Finland

Type 1 diabetes mellitus

1277.2

141.9

149

F34.1

ICD-10 Finland

Dysthymia

39.5

141.2

191

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

140.2

145

C09AA05

ATC

ramipril; oral

8.4

139.8

336

348

EP1AE

NOMESCO Finland

Neck ultrasound examination

11.0

138.9

287

225

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

61.4

138.9

174

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

599.7

134.3

143

N05AF03

ATC

chlorprothixene; systemic

1167.9

131.3

138

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.9

130.6

627

1482

N03AX16

ATC

pregabalin; oral

4.2

130.1

566

1223

SPAT1240

SPAT

Therapeutic discussion

3.8

129.9

628

1493

P03

ICPC

Feeling depressed

4.3

129.7

552

1168

N06AB05

ATC

paroxetine; oral

22.5

127.9

199

XCK10

NOMESCO Finland

Photography of fundus of eye

10.4

126.7

269

222

R53

ICD-10 Finland

Malaise and fatigue

3.3

126.1

743

2067

F32.1

ICD-10 Finland

Moderate depressive episode

10.2

125.6

269

226

A10BH01

ATC

sitagliptin; oral

1109.1

125.5

132

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.6

125.4

659

1677

I25.1

ICD-10 Finland

Atherosclerotic heart disease

95.8

125.1

148

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

556.3

124.6

133

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

78.4

123.0

149

N05AH02

ATC

clozapine; systemic

+∞

122.7

127

H02AB09

ATC

hydrocortisone; systemic

16.9

122.5

210

106

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

29.2

121.5

176

B01AA03

ATC

warfarin; systemic

36.1

121.2

167

N05AB03

ATC

perphenazine; systemic, rectal

117.5

120.7

140

E66.01

ICD-10 Finland

Obesity due to excess calories

6.4

120.7

350

478

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

+∞

116.8

121

N05BA12

ATC

alprazolam; oral

10.4

116.1

246

202

SPAT1249

SPAT

Treatment-related counselling outside office

2.3

115.7

1581

7165

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

16.8

115.4

198

100

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

+∞

114.9

119

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

265.7

114.8

126

N05BA06

ATC

lorazepam; systemic, sublingual

87.1

112.9

135

N05CD07

ATC

temazepam; oral

18.1

112.6

188

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

112.0

116

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

63.9

110.1

137

F31.8

ICD-10 Finland

Other bipolar affective disorders

149.4

110.0

125

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

7.4

109.8

286

334

F32

ICD-10 Finland

Depressive episode

10.5

109.8

231

187

F40.1

ICD-10 Finland

Social phobias

19.4

108.7

177

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

7.7

108.5

275

308

P01

ICPC

Feeling anxious/nervous/tense

3.0

108.4

730

2215

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

108.1

112

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

129.6

107.9

124

C09AA02

ATC

enalapril; systemic

6.8

106.9

296

378

I48

ICD-10 Finland

Atrial fibrillation and flutter

87.9

105.5

126

WX408

NOMESCO Finland

General anesthesy, balanced

2.7

105.2

863

2964

AA1AD

NOMESCO Finland

CT of head and brain

4.0

104.9

480

1076

N05CF02

ATC

zolpidem; oral

3.9

104.0

480

1084

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

907.7

103.2

109

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.9

103.0

280

348

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

8.8

102.6

239

233

130

Kela drug reimbursment

Malignant tumour

+∞

102.3

106

H3600, E103

ICD-10 Finland

+∞

102.3

106

F93.89

ICD-10 Finland

Other childhood emotional disorders

306.6

101.9

111

P99

ICPC

Psychological disorders other

18.8

101.4

167

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

+∞

101.3

105

101

Kela drug reimbursment

Anterior pituitary hypofunction

19.7

101.3

164

P29

ICPC

Psychological sympt/compl other

5.0

101.2

362

635

IGY02

NOMESCO Finland

Psychiatric monitoring contact

53.9

101.1

129

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

232.2

100.5

111

N05BE01

ATC

buspirone; oral

64.9

99.9

124

C10AA07

ATC

rosuvastatin; oral

4.1

99.0

436

942

177

Kela drug reimbursment

Insulin glargine 300 U / ml

856.4

97.4

103

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

856.4

97.4

103

N06AX22

ATC

agomelatine; oral

75.8

97.1

118

R06.0

ICD-10 Finland

Dyspnoea

3.2

97.1

601

1709

E23.00

ICD-10 Finland

Panhypopituitarism

179.9

96.3

108

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

51.4

95.6

123

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

95.5

E66.8

ICD-10 Finland

Other obesity

10.8

95.3

198

156

F90.0

ICD-10 Finland

Disturbance of activity and attention

9.1

95.2

216

201

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

176.5

94.4

106

P74

ICPC

Anxiety disorder/anxiety state

8.1

94.1

229

240

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

93.7

1269

5601

IGY99

NOMESCO Finland

Other psychiatric treatment contact

92.5

93.5

111

TPH04

NOMESCO Finland

Cathetrisation of vein

3.2

93.3

554

1526

XF400

NOMESCO Finland

ECG with 12 standard connections

4.7

93.0

350

647

N02AX02

ATC

tramadol; systemic, rectal

2.3

92.6

1060

4320

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

23.0

90.8

140

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

34.0

90.4

126

N05AD01

ATC

haloperidol; systemic

207.9

90.0

100

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

24.4

88.4

134

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.4

88.1

489

1277

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

16.1

88.0

153

N02AA05

ATC

oxycodone; systemic

8.4

87.3

208

210

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.6

86.3

758

2674

C07AB02

ATC

metoprolol; systemic

7.2

86.1

226

266

N03AE01

ATC

clonazepam; systemic

14.2

86.0

157

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.9

85.6

306

534

F61.0

ICD-10 Finland

Mixed personality disorders

117.6

85.5

F41.09

ICD-10 Finland

UNS Panic Syndrome

16.1

85.3

148

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

197.2

85.2

M79.6

ICD-10 Finland

Pain in limb

2.2

85.0

1045

4379

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

4.0

85.0

377

816

Z01.8

ICD-10 Finland

Other specified special examinations

2.7

84.7

656

2149

N06BA04

ATC

methylphenidate; oral

11.3

84.4

171

128

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

77.2

84.2

102

F20.9

ICD-10 Finland

Schizophrenia, unspecified

737.4

83.9

R5140

NOMESCO Finland

Monitoring the use of the aid

4.2

83.8

355

736

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

+∞

82.9

B01AB05

ATC

enoxaparin; parenteral

3.2

82.2

498

1385

R03AC02

ATC

salbutamol; inhalant

1.9

81.9

1908

10329

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

363.3

81.3

A06AC01

ATC

ispaghula (psylla seeds); oral

3.2

81.3

491

1362

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

81.0

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

68.6

80.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.5

80.1

429

1087

WZC30

NOMESCO Finland

Teaching

4.1

79.9

341

711

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.7

79.7

297

541

N03AX12

ATC

gabapentin; oral

4.0

79.4

356

777

A10BK01

ATC

dapagliflozin; oral

695.0

79.1

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

28.2

79.0

115

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

241.7

79.0

F51.0

ICD-10 Finland

Nonorganic insomnia

3.2

78.6

478

1330

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

10.5

77.6

163

131

N06AX03

ATC

mianserin; oral

44.6

77.5

102

H3601, E103

ICD-10 Finland

+∞

77.1

N07BB01

ATC

disulfiram; oral

7.5

77.0

196

220

N06AG02

ATC

moclobemide; oral

40.8

76.9

103

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

7.0

76.4

204

246

N06AX05

ATC

trazodone; oral

50.9

76.2

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

+∞

76.1

F31

ICD-10 Finland

Bipolar affective disorder

230.0

75.1

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

64.4

75.0

SPAT1301

SPAT

No procedures

2.1

74.9

1086

4853

TPH07

NOMESCO Finland

Cathetrisation of artery

7.5

74.7

190

213

A03FA01

ATC

metoclopramide; systemic, rectal

3.7

74.6

359

832

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

7.3

74.6

194

225

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

140.9

74.5

A11CC03

ATC

alfacalcidol; systemic

47.4

74.5

B01AC04

ATC

clopidogrel; oral

20.3

74.4

119

R07.4

ICD-10 Finland

Chest pain, unspecified

2.7

74.4

572

1855

P72

ICPC

Schizophrenia

+∞

74.2

WX402

NOMESCO Finland

General anaesthesia

2.9

74.0

527

1629

Z71.8

ICD-10 Finland

Other specified counselling

2.2

74.0

941

3967

H02AB06

ATC

prednisolone; systemic

2.0

73.8

1315

6377

T82

ICPC

Obesity

8.7

73.7

171

165

A02BC01

ATC

omeprazole; systemic

2.6

73.4

633

2194

F99

ICD-10 Finland

Mental disorder, not otherwise specified

39.2

73.4

SPAT1260

SPAT

Consultation of another employee

2.6

73.2

603

2036

E66.00

ICD-10 Finland

Metabolic syndrome

9.1

73.1

165

152

J01DB01

ATC

cefalexin; oral

1.9

72.8

3223

21347

XF404

NOMESCO Finland

Ambulatory ECG

9.1

72.8

165

153

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

14.0

72.0

132

C10AX09

ATC

ezetimibe; oral

9.1

71.9

163

151

WX110

NOMESCO Finland

Local anesthesy

1.8

71.9

2921

18729

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

5.4

71.4

232

362

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

10.8

70.9

146

113

SPAT1263

SPAT

Sampling

1.9

70.4

1624

8619

WX892

NOMESCO Finland

Monitored bed care

7.6

70.3

178

198

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

+∞

70.3

H3603, E103

ICD-10 Finland

+∞

70.3

AN1

Coronary angiography

42.9

70.2

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.8

70.1

528

1687

207

Kela drug reimbursment

Chronic arrhythmias

610.6

69.5

I50.9

ICD-10 Finland

Heart failure, unspecified

+∞

69.4

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

15.5

68.9

121

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.0

68.9

1209

5796

C03DA01

ATC

spironolactone; oral

11.4

68.9

138

101

SPAT1097

SPAT

Recording of ECG

4.5

68.7

267

507

XF402

NOMESCO Finland

ECG with work load test

7.7

68.6

171

186

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

+∞

68.4

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

+∞

68.4

S18

ICPC

Laceration/cut

2.0

67.9

1148

5423

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

15.5

67.8

119

E06.3

ICD-10 Finland

Autoimmune thyroiditis

37.7

67.0

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

299.8

67.0

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.7

66.9

326

762

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

4.6

66.9

255

475

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

93.4

66.7

A02BC05

ATC

esomeprazole; systemic

2.1

66.3

979

4375

A04

ICPC

Weakness/tiredness general

2.6

65.9

560

1918

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

65.5

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

35.5

65.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

65.3

1755

9724

P06

ICPC

Sleep disturbance

3.2

65.0

374

995

SPAT1307

SPAT

Psychosocial counselling and guidance

2.9

64.9

454

1382

R42

ICD-10 Finland

Dizziness and giddiness

2.9

64.7

435

1290

N06AA09

ATC

amitriptyline; systemic

8.5

64.7

152

150

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

+∞

64.5

N06AA12

ATC

doxepin; systemic

22.2

63.9

N06CA01

ATC

amitriptyline and psycholeptics; systemic

6.9

63.6

172

211

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

31.1

63.5

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

148.7

63.5

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

6.0

63.0

187

261

A10BJ06

ATC

semaglutide; parenteral

+∞

62.6

F41.00

ICD-10 Finland

Moderate panic disorder

77.5

62.1

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.2

62.0

759

3118

JN4BD

NOMESCO Finland

Extensive body CT

6.7

61.2

168

211

D64.9

ICD-10 Finland

Anaemia, unspecified

10.7

61.1

126

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

21.9

61.0

R50.9

ICD-10 Finland

Fever, unspecified

2.5

60.9

532

1843

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

535.0

60.8

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

+∞

60.7

N04AA02

ATC

biperiden; systemic

142.4

60.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

60.3

1216

6077

H02AB02

ATC

dexamethasone; systemic

15.2

60.0

106

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

17.7

59.9

100

C09CA01

ATC

losartan; oral

3.1

59.8

367

1021

F39

ICD-10 Finland

Unspecified mood [affective] disorder

26.7

59.2

SPAT1234

SPAT

Support of social functional capacity

13.0

59.0

111

UJF32

NOMESCO Finland

Coloscopy

2.7

58.9

465

1519

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

55.5

58.5

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.1

58.3

246

505

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

58.3

447

1436

SPAT1310

SPAT

Counselling related to known health issue

1.8

58.0

1206

6079

H36.00

ICD-10 Finland

Diabetic background retinopathy

509.9

58.0

P01AB01

ATC

metronidazole; oral, rectal

2.0

57.1

957

4456

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

56.8

R11

ICD-10 Finland

Nausea and vomiting

3.6

56.6

284

678

F60.9

ICD-10 Finland

Personality disorder, unspecified

46.4

56.0

C08CA13

ATC

lercanidipine; oral

7.5

55.7

141

157

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

8.5

55.7

130

127

R51.80

ICD-10 Finland

Headache

2.3

55.2

574

2172

R4110

NOMESCO Finland

Physiotherapy

2.3

54.9

610

2384

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.5

54.8

500

1769

ZX114

NOMESCO Finland

Intramuscular

15.5

54.2

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

+∞

53.9

TFP20

NOMESCO Finland

Cardiodefibrillation

+∞

53.9

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

53.9

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.7

53.8

256

585

I47.1

ICD-10 Finland

Supraventricular tachycardia

32.6

53.6

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

35.4

53.2

E66.9

ICD-10 Finland

Obesity, unspecified

7.2

52.9

137

158

N06AB08

ATC

fluvoxamine; oral

75.4

52.9

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.4

52.7

492

1760

F33

ICD-10 Finland

Recurrent depressive disorder

25.8

52.6

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

13.4

52.3

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.0

52.2

334

953

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

52.1

707

3014

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

+∞

52.0

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

+∞

52.0

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

52.0

2092

12757

SPAT1243

SPAT

Psychiatric/psychological examination

5.1

51.4

175

288

AA400

NOMESCO Finland

Electroconvulsive therapy

+∞

51.0

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

51.0

1365

7397

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.5

51.0

142

182

L03

ICPC

Low back symptom/complaint

2.0

50.8

779

3484

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

7.1

50.8

133

156

A06AD11

ATC

lactulose; oral

3.7

50.8

239

541

A10BD07

ATC

metformin and sitagliptin; systemic

443.0

50.3

A28

ICPC

Limited function/disability NOS

5.9

50.2

150

211

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.6

50.1

248

585

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

63.9

50.1

WX872

NOMESCO Finland

Intensive care

16.8

50.1

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

82.4

50.1

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

+∞

50.1

L03AA02

ATC

filgrastim; parenteral

+∞

50.1

N05AE04

ATC

ziprasidone; systemic

+∞

50.1

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

19.1

50.0

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

4.1

50.0

212

437

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

49.8

715

3112

TK800

NOMESCO Finland

Hemodialysis

41.9

49.8

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

49.3

545

2117

SPAT1252

SPAT

Overall medication plan or its review

7.8

49.2

121

129

K02.1

ICD-10 Finland

Caries of dentine

1.6

49.2

2584

16805

WX002

NOMESCO Finland

Sedation and analgesia

2.6

49.1

402

1337

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

+∞

49.1

127

Kela drug reimbursment

Transplant complication

38.9

49.1

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

6.5

48.9

136

174

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

7.5

48.9

123

136

XA800

NOMESCO Finland

Neuropsychological investigation

6.2

48.6

140

188

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

48.5

3035

20644

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

7.1

48.3

126

147

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

48.1

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.1

48.1

295

818

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.4

47.8

251

621

F43.1

ICD-10 Finland

Post-traumatic stress disorder

7.4

47.8

122

138

SPAT1312

SPAT

General health counselling

1.7

47.6

1414

7864

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

35.7

47.5

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.8

47.4

216

475

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

92.2

47.4

R4190

NOMESCO Finland

Nutritional therapy

6.5

47.3

132

170

A10AB06

ATC

insulin glulisine; parenteral

+∞

47.2

F10.20

ICD-10 Finland

Alcohol dependence currently independent

17.9

47.1

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

145.3

46.7

EBA15

NOMESCO Finland

Extraction of large number of teeth

7.8

46.7

115

123

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

46.7

784

3620

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

8.5

46.5

108

105

C09CA06

ATC

candesartan; oral

2.5

46.5

413

1434

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

17.7

46.3

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

46.2

1247

6729

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

46.2

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

209.9

46.0

ZXA10

NOMESCO Finland

Bilateral

2.4

45.8

438

1579

J01MA12

ATC

levofloxacin; systemic

2.6

45.7

360

1169

TFP34

NOMESCO Finland

Electrophysiological investigation

109.0

45.6

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

23.7

45.6

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

401.3

45.5

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.6

45.4

168

303

H01AC01

ATC

somatropin; parenteral

13.7

45.4

F41.8

ICD-10 Finland

Other specified anxiety disorders

6.3

45.2

129

171

4CJ01

NOMESCO Finland

+∞

45.2

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

10.9

45.2

J01AA02

ATC

doxycycline; systemic

1.6

45.2

2234

14158

RD210

NOMESCO Finland

8.6

45.1

104

100

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

57.7

44.7

C01DA14

ATC

isosorbide mononitrate; oral

87.2

44.6

M25.5

ICD-10 Finland

Pain in joint

1.8

44.3

857

4152

G44.2

ICD-10 Finland

Tension-type headache

2.5

44.2

394

1369

E23.05

ICD-10 Finland

Lack of TSH

201.3

44.1

L28

ICPC

Limited function/disability (L)

3.5

44.0

226

549

SPAT1153

SPAT

Removal of sutures

1.9

43.6

708

3218

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.6

43.5

362

1212

JN4AD

NOMESCO Finland

Body CT examination

9.8

43.2

TPX10

NOMESCO Finland

Implantation of vascular injection port

14.9

43.0

SPAT1216

SPAT

Assessment of functional ability

3.2

43.0

242

631

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

50.3

42.9

J01FF01

ATC

clindamycin; systemic

1.9

42.7

759

3563

A46

ICD-10 Finland

Erysipelas

2.8

42.6

297

895

L17

ICPC

Foot/toe symptom/complaint

1.9

42.6

705

3226

J02AC01

ATC

fluconazole; systemic

1.8

42.4

816

3939

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

42.3

H36.01

ICD-10 Finland

Diabetic maculopathy

193.0

42.3

ZX120

NOMESCO Finland

Intravenous

3.6

41.7

206

485

M04AA01

ATC

allopurinol; systemic

4.4

41.7

163

311

C07AG02

ATC

carvedilol; oral

23.6

41.6

N05AL01

ATC

sulpiride; systemic

188.8

41.3

IGV01

NOMESCO Finland

Psychiatric network contact

188.8

41.3

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.3

41.3

440

1672

M54.5

ICD-10 Finland

Low back pain

1.7

41.1

1041

5478

N05AA01

ATC

chlorpromazine; systemic, rectal

128.7

41.1

XCK00

NOMESCO Finland

Perimetry

5.0

41.0

142

239

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

41.0

1899

11731

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

16.0

40.8

C08CA02

ATC

felodipine; oral

12.5

40.5

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

40.4

448

1733

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

40.4

WX290

NOMESCO Finland

Other blockade of nerve

1.5

40.4

2168

13853

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

11.4

40.3

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.3

40.2

225

583

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

18.1

40.2

E66

ICD-10 Finland

Obesity

4.9

40.1

141

241

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

52.3

40.1

201

Kela drug reimbursment

Chronic cardiac insufficiency

34.8

40.1

M01AE02

ATC

naproxen; oral, rectal

1.5

40.0

2173

13911

CKC12

NOMESCO Finland

Photocoagulation of retina

6.8

40.0

107

130

P15

ICPC

Chronic alcohol abuse

6.6

39.6

109

138

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

+∞

39.4

A10BH05

ATC

linagliptin; oral

+∞

39.4

A10AA03

ATC

+∞

39.4

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

39.3

1258

7057

A04AA02

ATC

granisetron; systemic, transdermal

123.1

39.2

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

38.8

410

1552

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

4.1

38.7

164

338

SPAT1281

SPAT

Other administrative function

2.8

38.7

280

862

SPAT1283

SPAT

Restricted health certificate

1.7

38.6

1102

5984

E03.1

ICD-10 Finland

Congenital hypothyroidism without goitre

+∞

38.5

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

38.5

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

+∞

38.5

I50.1

ICD-10 Finland

Left ventricular failure

+∞

38.5

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

38.5

XF600

NOMESCO Finland

Bloodpressure measurement

4.0

38.4

164

341

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

38.1

2068

13173

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

4.8

38.0

136

237

WF002

NOMESCO Finland

Radical radiotherapy

29.6

38.0

XX3DW

NOMESCO Finland

Time consuming IT work

4.4

37.9

147

279

XW000

NOMESCO Finland

Bone marrow biopsy

9.9

37.6

N06AA06

ATC

trimipramine; systemic

18.6

37.5

I20.09

ICD-10 Finland

Unstable angina

+∞

37.5

160

Kela drug reimbursment

exenatide

+∞

37.5

UKC02

NOMESCO Finland

Cystoscopy

3.1

37.3

224

611

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

6.5

37.3

103

131

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

117.6

37.3

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

117.6

37.3

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

117.6

37.3

F50.9

ICD-10 Finland

Eating disorder, unspecified

8.7

37.2

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

16.2

36.9

C09BA02

ATC

enalapril and diuretics; systemic

9.7

36.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

36.7

292

950

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

43.8

36.7

IBA03

NOMESCO Finland

Psychotherapy evaluation

43.8

36.7

D11

ICPC

Diarrhoea

2.1

36.6

489

2049

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

+∞

36.6

A10BJ02

ATC

liraglutide; parenteral

+∞

36.6

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

+∞

36.6

Z94.0

ICD-10 Finland

Kidney transplant status

48.2

36.5

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

9.8

36.4

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

114.8

36.4

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

17.6

36.3

C02AC05

ATC

moxonidine; oral

24.7

36.2

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

318.1

36.0

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

35.8

741

3641

JN3AD

NOMESCO Finland

Abdominal CT examination

4.0

35.7

154

323

XKD00

NOMESCO Finland

Uroflowmetry

3.2

35.6

203

534

B01AC24

ATC

ticagrelor; oral

+∞

35.6

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

+∞

35.6

I20.99

ICD-10 Finland

Angina pectoris, unspecified

+∞

35.6

A10BG03

ATC

pioglitazone; oral

+∞

35.6

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

35.6

N03AF02

ATC

oxcarbazepine; oral

5.0

35.4

121

201

N18.8

ICD-10 Finland

Other chronic renal failure

27.9

35.4

R02

ICPC

Shortness of breath/dyspnoea

2.5

35.3

293

977

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

35.8

35.3

X78

ICD-10 Finland

Intentional self-harm by sharp object

35.8

35.3

R00.0

ICD-10 Finland

Tachycardia, unspecified

4.8

35.2

126

220

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

35.1

2243

14708

A02BC03

ATC

lansoprazole; oral

2.0

34.8

505

2188

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

+∞

34.6

I25.2

ICD-10 Finland

Old myocardial infarction

+∞

34.6

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

+∞

34.6

C03AA03

ATC

hydrochlorothiazide; oral

14.2

34.6

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

109.3

34.5

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.0

34.5

147

305

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

460

229

11.82

322.61

2.9

2.0

0.9

0.8

nmol/l

1.41

358

212

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

557

388

8.48

320.06

2.7

2.6

19.4

21.6

nmol/l

2.86

528

383

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

12339

54838

1.89

318.56

3.5

2.0

43.9

31.2

u/l

57.34

11751

52797

(3021387) Prolactin [Units/volume] in Serum or Plasma

1870

3946

2.92

317.09

2.0

1.4

333.2

269.8

mu/l

7.47

1654

3601

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1661

3284

3.10

313.82

3.1

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

14519

68377

2.03

312.55

16.7

6.1

13.5

13.3

18.49

14255

66656

(3005719) IgG [Mass/volume] in Serum or Plasma

1660

3291

3.09

312.18

2.8

2.2

10.6

10.9

g/l

1.75

1507

3029

(3042936) Bacteria identified in Isolate by Culture

2288

5447

2.62

310.94

2.1

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7099

26667

1.86

309.11

3.6

2.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1521

2657

3.50

307.65

1.5

1.3

8.3

7.9

u/l

0.47

1235

2240

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7861

13898

4.92

307.65

7.0

2.9

1.2

mmol/l

26.53

7212

12358

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13085

40434

3.95

307.65

7.7

3.9

74.5

70.9

u/l

22.51

12392

37677

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2250

3849

3.69

307.65

2.8

1.5

29.9

28.7

14.68

2179

3726

(3015377) Calcium [Moles/volume] in Serum or Plasma

6118

11183

4.21

307.65

3.2

1.5

2.3

mmol/l

17.48

5539

9845

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15968

77565

2.36

307.65

4.5

2.6

1.4

1.5

mmol/l

219.54

15086

74140

(3021589) Normoblasts [#/volume] in Blood

8242

26640

2.41

307.65

9.9

5.4

0.0

e9/l

0.28

6959

22156

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4104

12068

2.23

307.65

2.2

1.5

—

(3002032) Base excess in Venous blood by calculation

1413

1820

4.75

307.65

4.6

2.4

1.7

1.9

mmol/l

1.22

1126

1476

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1110

1444

4.64

307.65

3.8

2.8

5.1

kpa

0.21

1038

1344

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1562

1901

5.07

307.65

8.8

5.3

5.1

5.0

kpa

2.92

1490

1817

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1061

1388

4.60

307.65

7.8

5.9

24.5

24.7

mmol/l

0.69

1051

1383

(3016502) Oxygen saturation in Arterial blood

1412

1609

5.38

307.65

9.4

5.7

96.0

96.6

1.60

1356

1539

(42870588) Differential panel, method unspecified - Blood

6123

16320

2.73

307.65

6.2

5.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

4482

12694

2.36

307.65

2.5

1.6

2264.3

3490.4

umol/l

1.76

3988

11515

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

16821

77283

3.82

307.65

13.7

5.3

18.2

20.9

mg/l

22.90

13697

53721

(36304419) Bacteria [Presence] in Urine

4281

12215

2.32

307.65

2.9

2.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

1134

1568

4.37

307.65

4.2

2.3

4.8

kpa

0.05

1092

1526

(3031040) Bacteria [#/volume] in Urine by Automated count

11168

42308

2.31

307.65

4.3

2.8

1019.6

1309.3

e6/l

0.35

162

426

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4962

9291

3.83

307.65

2.3

1.8

2.7

2.4

mg/l

20.72

4259

7920

(3013707) Erythrocyte sedimentation rate by Westergren method

13244

47259

3.16

307.65

4.2

2.9

9.8

7.7

mm/h

85.73

12405

44317

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6421

17040

2.79

307.65

3.3

2.1

31.3

28.7

u/l

3.75

6110

16383

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2857

5178

3.57

307.65

2.8

1.6

2.4

mmol/l

1.18

2516

4448

(3037467) Urinalysis macro (dipstick) panel - Urine

11783

46307

2.28

307.65

4.3

2.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1443

1178

7.56

307.65

2.3

2.1

33.9

3.6

iu/l

0.53

697

508

(3026008) Bacteria identified in Urine by Culture

4572

13505

2.26

307.65

2.5

1.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2783

3800

4.78

307.65

2.6

1.5

2.4

2.5

g/l

5.29

2541

3543

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

16201

78371

2.54

307.65

4.9

2.7

2.8

3.1

mmol/l

181.02

15286

74291

(3030467) Casts [#/volume] in Urine by Automated count

4287

11849

2.41

307.65

3.0

2.1

0.3

e6/l

0.41

3287

8222

(3037522) Nuclear Ab [Titer] in Serum

3190

8026

2.55

307.65

1.4

1.3

556.1

581.2

titre

0.26

697

1505

(3022217) INR in Platelet poor plasma by Coagulation assay

1455

2441

3.64

307.65

16.5

2.2

1.1

1.0

inr

4.49

227

494

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

968

241

24.32

307.65

6.7

1.3

79.6

152.6

u/ml

0.50

391

(3021601) Nitrite [Presence] in Urine by Test strip

8853

33338

2.01

307.65

4.6

3.4

0.0

estimate

1.23

2094

5877

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3346

3924

5.77

307.65

3.2

1.3

824.4

259.5

ng/l

11.95

2669

2883

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15770

69508

3.09

307.65

4.5

2.4

5.9

5.4

mmol/l

286.05

14807

65274

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

883

954

5.54

307.65

11.0

7.6

0.7

0.74

878

949

(40761511) CBC panel - Blood by Automated count

17534

86182

4.36

307.65

13.6

4.9

—

(4035726)

1318

1821

4.41

307.65

1.4

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8705

21101

3.60

307.65

6.0

2.6

10.1

11.2

umol/l

12.19

8158

19672

(3044640) Blood type and Crossmatch panel - Blood

5473

16492

2.29

307.65

2.3

1.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1562

1900

5.07

307.65

8.8

5.3

12.6

14.3

kpa

16.35

1491

1817

(3019060) Gas panel - Arterial blood

886

971

5.46

307.65

6.0

3.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

17426

82731

4.74

307.65

15.1

4.9

73.3

71.0

umol/l

18.05

17421

82643

(3028707) Methadone [Presence] in Urine by Screen method

712

509

8.33

307.65

2.8

1.8

—

(3026782) Osmolality of Urine

3242

7658

2.74

307.65

2.8

1.8

542.1

580.2

mosm/kgh2o

12.77

2799

6333

(3007164) IgA [Mass/volume] in Serum or Plasma

4780

13153

2.47

307.65

1.5

1.3

2.2

2.1

g/l

1.54

3074

8885

(3009343) pH of Capillary blood

1093

1424

4.63

307.65

3.8

2.8

7.4

3.29

161

122

(3024561) Albumin [Mass/volume] in Serum or Plasma

7066

15136

3.73

307.65

5.1

3.0

36.6

37.7

g/l

47.43

6590

14013

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2529

3332

4.90

307.65

2.7

1.6

24.2

27.1

14.10

2155

2901

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5769

15641

2.63

307.65

1.4

1.2

1.6

2.0

u/ml

1.45

1822

4682

(40758558) Short blood count panel - Blood

4478

11934

2.53

307.65

7.1

3.9

—

(3044889) 12 lead EKG panel

11187

36624

2.92

307.65

3.4

1.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1072

1371

4.71

307.65

3.8

2.8

1.3

1.2

mmol/l

0.12

769

970

(3035350) Ketones [Presence] in Urine by Test strip

8863

33180

2.03

307.65

3.5

2.4

0.0

estimate

1.08

2030

5630

(3019225) pH of Specimen

1668

3065

3.34

307.65

4.6

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2341

4874

3.02

307.65

1.9

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

15484

74157

2.24

307.65

4.1

2.5

1.4

1.2

mmol/l

139.95

14597

70924

(40760892) CBC W Ordered Manual Differential panel - Blood

4969

15595

2.14

307.65

4.5

3.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8695

16015

5.01

307.65

7.8

3.1

1.2

mmol/l

34.71

7231

13748

(3009261) Glucose [Presence] in Urine by Test strip

8918

33656

2.01

307.65

3.5

2.4

0.0

estimate

0.96

2006

5834

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

741

108.25

307.65

8.2

2.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3984

6950

3.93

307.65

1.7

1.3

29883126.3

48389100.1

pmol/l

0.90

3410

6144

(3029937) Albumin [Presence] in Urine by Test strip

5113

16806

2.04

307.65

3.9

2.5

0.0

estimate

0.25

2038

5787

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

889

973

5.47

307.65

3.4

1.4

122.5

62.0

ng/l

1.82

788

849

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1711

1550

6.90

307.65

3.9

2.6

72.4

65.7

ng/l

1.29

1527

1393

(3027945) Reticulocytes/100 erythrocytes in Blood

1622

2318

4.32

307.65

3.0

1.9

1.8

1.5

22.34

1445

2064

(3009508) Creatinine [Moles/volume] in Urine

5398

7746

5.25

307.65

3.7

1.9

8.1

8.9

mmol/l

16.39

4699

6796

(3001604) Monocytes [#/volume] in Blood

9221

28688

2.69

307.65

6.4

4.7

0.6

0.5

e9/l

13.89

8238

25625

(3001122) Ferritin [Mass/volume] in Serum or Plasma

10191

31235

2.96

307.65

3.5

2.2

91.3

70.8

ug/l

23.25

9603

29851

(3019550) Sodium [Moles/volume] in Serum or Plasma

16881

69435

5.63

307.65

14.5

4.2

139.5

139.8

mmol/l

39.24

16471

66734

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1746

2492

4.35

307.65

4.9

2.5

228.0

219.0

u/l

2.46

1658

2369

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1421

1840

4.73

307.65

4.6

2.4

5.9

5.8

kpa

0.36

1369

1791

(3021960) Folate [Moles/volume] in Serum or Plasma

3725

6659

3.78

307.65

1.5

1.2

19.9

21.3

nmol/l

5.61

3300

5749

(3014576) Chloride [Moles/volume] in Serum or Plasma

1786

2478

4.48

307.65

8.3

4.5

104.5

105.1

mmol/l

4.10

1753

2433

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8172

29413

2.07

307.65

4.2

3.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

3077

4469

4.55

307.65

2.6

1.5

14.4

21.0

umol/l

0.83

2833

4163

(3013512) EKG study

4328

9459

3.13

307.65

3.4

1.7

—

(3023368) Bacteria identified in Blood by Culture

3726

7866

3.16

307.65

4.3

2.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1412

1428

6.08

307.65

10.1

3.8

8.2

6.3

mmol/l

19.43

1347

1366

(3002030) Lymphocytes/100 leukocytes in Blood

8961

29230

2.48

307.65

6.5

4.5

29.8

31.0

21.11

8407

27605

(3003396) Base excess in Arterial blood by calculation

1576

1897

5.13

307.65

8.8

5.3

0.8

mmol/l

0.19

1207

1373

(3012516) Albumin [Mass/volume] in Urine

4547

5447

6.04

307.65

3.8

1.9

475.6

706.8

mg/l

1.21

2960

2932

(3006315) Basophils [#/volume] in Blood

9266

28772

2.71

307.65

6.4

4.7

0.0

e9/l

1.79

8257

25668

(3014111) Lactate [Moles/volume] in Serum or Plasma

1315

1728

4.64

307.65

8.3

5.0

1.3

mmol/l

0.19

1262

1666

(3008152) Bicarbonate [Moles/volume] in Arterial blood

891

1029

5.18

307.65

8.2

4.1

24.3

mmol/l

0.09

831

936

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4881

9657

3.59

307.65

2.3

1.6

190.3

205.2

u/l

0.33

4611

9137

(3018010) Neutrophils/100 leukocytes in Blood

8831

28865

2.46

307.65

6.3

4.5

55.8

55.3

3.92

8316

27432

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6827

14174

3.81

307.65

1.9

1.4

98.2

100.3

pmol/l

2.43

3910

7291

(3035637) Corticotropin [Mass/volume] in Plasma

542

288

11.12

307.65

1.8

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3077

2744

7.54

307.65

2.7

1.7

369.4

383.1

nmol/l

2.16

2816

2566

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4527

13455

2.24

307.65

1.8

1.4

1.5

1.2

mmol/l

41.12

3799

11988

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1305

1532

5.20

307.65

9.7

5.9

124.8

127.7

g/l

3.39

1259

1460

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2416

2688

5.80

307.65

6.7

3.5

1.1

1.0

mmol/l

2.61

2251

2505

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

15660

67459

3.20

307.65

11.8

4.1

91.2

92.0

ml/min/173m2

5.32

13142

52115

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5736

13967

2.98

307.65

3.0

1.7

55.5

59.3

u/l

2.10

5309

12986

(3022096) Basophils/100 leukocytes in Blood

8279

26177

2.48

307.65

6.5

4.8

0.7

0.45

7746

24629

(3032080) INR in Blood by Coagulation assay

5630

11484

3.62

307.65

6.9

2.0

1.1

inr

1.29

1958

3892

(3013650) Neutrophils [#/volume] in Blood by Automated count

10392

32275

2.95

307.65

9.7

4.8

3.9

e9/l

1.39

9312

28405

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14971

60944

3.18

307.65

5.9

2.3

39.4

35.6

mmol/mol

307.65

14140

57773

(3013115) Eosinophils [#/volume] in Blood

9571

30095

2.72

307.65

6.7

4.6

0.2

e9/l

4.93

8649

27199

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

17990

50614

41.27

307.65

10.3

2.1

15.3

14.2

pmol/l

307.65

17395

46383

(3012544) pH of Venous blood

1447

1893

4.69

307.65

4.7

2.3

7.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4407

2083

15.67

307.65

4.4

3.2

4.5

4.8

pmol/l

18.63

4003

1921

(3023520) Reticulocytes [#/volume] in Blood

1172

1435

4.95

307.65

2.7

1.8

73.6

66.2

e9/l

7.06

894

1039

(3000991) Gas panel - Venous blood

1293

1606

4.90

307.65

9.8

5.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4722

4292

8.16

307.65

1.3

1.2

212.2

112.3

iu/ml

31.20

2168

1607

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

16062

77970

2.42

307.65

4.5

2.7

4.7

5.0

mmol/l

240.53

15222

74506

(3020630) Protein [Mass/volume] in Serum or Plasma

1120

1602

4.22

307.65

2.7

1.4

66.6

68.5

g/l

11.03

1045

1494

(3019069) Monocytes/100 leukocytes in Blood

8613

27449

2.51

307.65

6.8

4.8

8.2

8.1

2.02

8104

26022

(3019198) Lymphocytes [#/volume] in Blood

9577

30418

2.68

307.65

6.4

4.6

2.0

e9/l

0.79

8695

27646

(3018418) pH of Serum or Plasma

5380

8518

4.71

307.65

5.0

2.0

7.4

1.70

1189

1283

(3013826) Glucose [Moles/volume] in Serum or Plasma

9849

26693

3.40

307.65

5.2

2.5

6.7

5.9

mmol/l

143.26

9052

22879

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4201

10649

2.64

307.65

2.1

1.4

1.0

0.8

mg/l

2.08

3087

7697

(3033658) Prothrombin time (PT) actual/Normal

4059

10291

2.63

307.65

4.0

2.2

96.2

97.3

1.85

3912

9985

(3020682) Albumin/Creatinine [Ratio] in Urine

4759

5715

6.10

307.65

4.7

2.1

10.0

15.6

mg/mmol

0.91

3148

3159

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

18106

64121

32.75

307.65

11.6

2.4

2.3

mu/l

0.12

17443

59872

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1630

1948

5.18

307.65

4.1

1.7

1.2

mmol/l

7.75

1411

1645

(3018095) Leukocytes [#/volume] in Urine

5743

18133

2.19

307.65

3.7

2.4

61.6

67.0

e6/l

0.31

4025

10910

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2908

3313

5.80

307.65

3.9

2.1

0.8

mmol/l

19.00

2724

3081

(3006504) Eosinophils/100 leukocytes in Blood

8561

27272

2.50

307.65

6.5

4.7

2.9

0.51

8000

25629

(3002582) Erythrocytes [#/volume] in Urine

4731

13392

2.39

307.65

3.2

2.1

79.1

70.6

e6/l

0.12

3693

9535

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

448

119

22.17

307.65

2.6

2.1

126.7

72.8

ug/min

0.64

302

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1555

2261

4.23

307.65

2.6

2.1

0.2

g/l

5.81

1449

2132

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8463

21385

3.36

307.65

2.5

1.9

73.8

75.2

nmol/l

4.28

7883

20056

(3001019) Free T4 and TSH panel - Serum or Plasma

2784

5604

3.19

307.65

2.6

1.3

—

(40768797) Stomach Pathology biopsy report

2495

5849

2.68

307.65

1.2

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

3024

3846

5.21

307.65

1.8

1.5

1189.0

1143.8

nmol/l

1.46

2401

2840

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5640

13045

3.14

307.65

3.2

1.5

39.9

15.4

ng/l

4.01

2951

4535

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

17506

84717

4.62

307.65

11.0

4.8

27.7

25.5

u/l

31.15

17071

81813

(3009466) Valproate [Moles/volume] in Serum or Plasma

492

188

15.44

307.65

6.6

2.7

392.7

387.8

umol/l

0.15

433

152

(3023103) Potassium [Moles/volume] in Serum or Plasma

16918

69903

5.67

307.65

14.6

4.2

3.9

mmol/l

0.01

16475

66970

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1078

1246

5.22

307.65

2.3

1.3

7.7

3.4

ug/l

5.73

961

1085

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2527

5240

3.05

307.65

3.5

1.6

332.8

286.6

ng/l

0.20

1526

2386

(3000850) Epithelial cells [#/volume] in Urine

3441

8628

2.59

307.65

2.6

1.8

6.7

6.5

e6/l

0.27

3044

7302

(3004119) Hemoglobin [Mass/volume] in Venous blood

889

1115

4.77

307.22

4.0

2.0

131.2

139.8

g/l

17.83

864

1101

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

382

143

15.67

305.38

5.8

2.3

0.3

u/ml

0.28

221

(3007853) Bacteria identified in Skin by Aerobe culture

2255

5380

2.61

304.83

1.8

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2015

4573

2.72

299.24

2.7

1.9

6.7

6.3

umol/l

0.44

1718

3931

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3719

11258

2.13

295.57

1.3

1.2

29.3

31.8

iu/ml

0.13

1103

3725

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1508

2954

3.11

288.37

1.8

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3541

10605

2.14

288.30

1.3

1.2

9.8

11.3

u/ml

0.64

1549

4677

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1483

2885

3.13

286.70

1.7

1.3

—

(3010421) pH of Blood

569

480

7.00

284.04

3.5

1.9

7.4

2.74

482

392

(40768804) Tissue Pathology biopsy report

6823

25831

1.82

283.27

2.0

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2003

4709

2.62

277.19

6.3

2.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2998

8510

2.23

277.09

1.9

1.4

1.2

69.11

2673

7959

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

747

899

4.94

269.40

12.1

6.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

466

323

8.49

268.45

1.2

1.1

1980.3

9.0

iu/ml

0.54

140

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

793

1034

4.56

262.02

5.2

2.4

23.9

24.4

mmol/l

3.14

717

934

(3004588) Protein electrophoresis panel - Serum or Plasma

867

1225

4.22

260.89

2.3

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

548

492

6.57

259.97

2.8

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

1631

3552

2.80

259.55

4.3

3.7

0.9

0.5

5.30

395

498

(3007461) Platelets [#/volume] in Blood

18213

97036

6.74

258.94

21.8

7.4

262.2

257.2

e9/l

22.44

17976

94159

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1163

2064

3.39

258.17

1.6

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

492

399

7.26

253.10

3.7

1.9

9.0

9.2

kpa

1.70

484

393

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

703

847

4.92

253.08

11.7

7.7

24.2

24.3

mmol/l

0.27

667

805

(3012501) Base excess in Blood by calculation

489

398

7.23

250.85

3.7

1.9

2.2

1.8

mmol/l

2.25

312

222

(3013290) Carbon dioxide [Partial pressure] in Blood

489

398

7.23

250.85

3.7

1.9

5.0

4.9

kpa

1.44

481

392

(3035941) MCH [Entitic mass]

18216

97268

6.63

250.50

21.6

7.4

30.1

0.28

18083

95895

(3028026) IgM [Mass/volume] in Serum or Plasma

1271

2446

3.14

248.99

1.8

1.6

1.2

1.3

g/l

1.08

1166

2286

(3024731) MCV [Entitic volume]

18214

97288

6.56

248.86

21.7

7.4

90.1

89.8

23.89

18082

95902

(1616796) Gas panel - Central venous blood

482

389

7.29

248.86

3.4

2.0

—

(3026361) Erythrocytes [#/volume] in Blood

18216

97315

6.59

248.55

21.8

7.4

4.6

e12/l

47.78

17950

94268

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

275

21.68

247.11

1.5

1.2

14.6

13.7

pmol/l

0.83

234

(3010813) Leukocytes [#/volume] in Blood

18218

97375

6.60

246.88

21.8

7.4

6.7

6.5

e9/l

44.98

17951

94287

(3000963) Hemoglobin [Mass/volume] in Blood

18218

97416

6.56

245.18

21.9

7.4

136.4

138.5

g/l

82.96

18086

96044

(3022313) Gas panel - Capillary blood

785

1078

4.33

244.17

3.7

2.9

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

699

867

4.78

243.88

3.6

2.2

25.0

25.4

mmol/l

1.80

668

832

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

655

773

5.02

240.86

1.3

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1510

3309

2.77

236.84

4.0

3.5

0.7

0.3

4.91

285

376

(3021440) Promyelocytes/100 leukocytes in Blood

1554

3483

2.71

233.75

4.4

3.8

0.1

0.0

0.82

360

472

(3023183) Ammonium ion [Moles/volume] in Plasma

409

288

8.33

232.99

3.4

2.9

35.2

34.6

umol/l

0.12

350

244

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1922

4806

2.45

232.95

3.1

1.8

11.3

13.8

nmol/l

29.07

1729

4503

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

642

779

4.87

229.21

2.1

1.7

1.4

1.1

g/l

6.99

548

672

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

656

821

4.73

226.51

3.6

1.8

0.7

0.12

636

769

(3020891) Body temperature

587

667

5.20

224.27

5.2

2.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1925

4908

2.40

223.44

1.4

1.2

20.9

25.6

iu/l

7.54

1630

4331

(3018405) Lactate [Moles/volume] in Arterial blood

513

518

5.83

219.49

4.4

2.7

1.3

mmol/l

0.32

505

513

(3025159) Blasts/100 leukocytes in Blood

1487

3373

2.67

218.18

4.4

3.8

0.1

0.0

0.60

308

409

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1031

1891

3.26

217.06

3.7

2.0

24.8

7.9

ug/l

0.79

782

1243

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2450

7036

2.16

215.82

2.6

1.9

1.1

0.9

e6/l

1.30

1379

3738

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

564

642

5.18

215.04

2.5

2.0

449.8

422.4

ug/l

0.08

516

570

(40761536) Microorganisms panel - Urine sediment

1958

5137

2.33

213.00

3.5

2.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1575

3739

2.56

211.33

2.5

1.8

35.4

43.5

u/l

1.76

1352

3229

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

252

+∞

209.65

17.3

0.0

1375.0

—

nmol/l

—

241

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

629

820

4.53

207.43

4.4

2.3

52.1

47.0

3.62

618

814

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

513

554

5.45

205.99

2.2

1.6

1.8

1.7

ug/l

0.08

461

479

(3048689) Calprotectin [Mass/mass] in Stool

2930

9165

2.00

205.67

2.2

2.8

125.6

119.1

ug/g

0.37

2288

7418

(3019150) Specific gravity of Urine by Refractometry

3842

13252

1.84

201.69

3.9

2.5

1.0

kg/l

1.40

508

2224

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

242

+∞

201.30

12.7

0.0

769.8

—

nmol/l

—

232

(3011985) Renin [Units/volume] in Plasma

359

260

8.08

200.50

2.4

1.6

78.7

42.8

mu/l

1.96

326

245

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2307

6655

2.14

199.92

2.9

1.9

3.6

3.3

e6/l

0.49

1237

3383

(3041096) Erythrocytes [Presence] in Urine by Automated

5272

20107

1.71

196.35

3.0

2.1

—

(40767503) Oxygen content in Capillary blood by calculation

412

374

6.46

193.43

2.8

1.5

17.1

18.5

6.14

211

163

(3015235) Bicarbonate [Moles/volume] in Capillary blood

440

438

5.89

190.60

4.0

2.4

24.1

24.4

mmol/l

0.69

396

381

(3011397) Hemoglobin [Presence] in Urine by Test strip

3915

13798

1.80

190.30

3.5

2.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

440

442

5.84

189.03

4.8

2.8

3.8

mmol/l

0.38

410

423

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

687

1040

3.91

189.02

3.7

2.9

24.6

24.7

mmol/l

0.40

641

990

(3000570) Elastase.pancreatic [Mass/mass] in Stool

558

713

4.61

188.08

1.4

1.3

293.8

336.6

ug/g

3.31

295

365

(36660697) Celiac disease serology panel - Serum

1966

5469

2.19

185.42

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1030

2093

2.94

183.23

1.3

1.2

0.8

0.7

u/ml

0.21

134

(4146454)

181

30.91

178.75

3.3

1.3

—

(3036489) Thrombin time

741

1243

3.53

177.39

2.6

1.6

20.9

20.4

2.12

604

1021

(44816559) Phosphatidylethanol [Mass/volume] in Blood

546

726

4.43

175.86

1.4

1.2

—

(40761535) Cells panel - Urine sediment

1334

3189

2.52

175.40

3.5

2.4

—

(3008295) Osmolality of Serum or Plasma

269

153

10.25

175.19

1.9

1.5

286.2

285.5

mosm/kgh2o

0.15

220

122

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

757

1307

3.43

173.84

1.6

1.2

—

(3021901) Oxygen saturation in Capillary blood

329

258

7.45

173.43

2.9

2.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3122

10519

1.85

173.29

1.7

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

200

19.05

172.49

1.3

1.5

1.7

nmol/l

0.65

174

(3002256) Pathology report gross observation

2143

6359

2.06

171.01

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

276

177

9.09

167.14

1.7

1.6

71.7

76.1

mmol/l

0.37

223

144

(3022145) Colonoscopy Study observation

1961

5679

2.10

166.41

1.3

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

795

1466

3.21

165.30

1.7

1.4

0.5

nmol/l

0.50

659

1260

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

549

789

4.09

161.10

6.3

2.8

1.7

1.6

0.64

511

743

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

449

548

4.80

159.00

1.2

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

534

763

4.12

157.80

6.6

2.8

0.9

0.52

497

720

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

909

1873

2.88

157.47

2.1

2.0

39.3

40.7

u/l

1.24

837

1803

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

648

1082

3.53

155.95

3.5

1.7

93.8

92.6

0.55

591

983

(3000494) Fungus identified in Specimen by Culture

2077

6305

2.01

154.99

1.5

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

323

286

6.59

154.76

1.6

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

732

1338

3.24

154.16

2.0

1.8

0.2

g/l

2.92

690

1275

(3011288) Drugs identified in Urine by Screen method

997

2189

2.71

154.08

3.0

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

748

1395

3.17

152.67

2.0

1.8

1.2

1.1

g/l

6.81

706

1333

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

664

1186

3.30

144.75

1.5

1.2

17.7

19.9

u/l

0.97

557

996

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

646

1139

3.34

143.58

1.8

1.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

304

274

6.47

143.52

2.2

1.3

1.7

1.6

mmol/l

0.62

299

269

(3028626) Oxygen [Partial pressure] in Capillary blood

439

578

4.45

142.89

3.9

9.0

9.2

kpa

1.18

413

543

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

903

1963

2.73

141.93

1.6

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

290

253

6.68

140.65

1.5

1.2

398.5

294.1

pmol/l

1.68

223

192

(3009445) Proteinase 3 Ab [Units/volume] in Serum

767

1528

2.97

140.51

1.6

10.0

11.5

u/ml

0.19

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1302

3410

2.29

139.79

2.7

1.5

72.2

83.8

ml/min/173m2

15.34

522

1029

(3024928) Oxygen saturation in Venous blood

324

332

5.70

136.60

4.6

2.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

433

589

4.31

135.68

5.5

3.4

1195.2

691.4

iu/ml

0.26

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

574

977

3.46

134.28

4.5

2.8

1.4

1.0

mg/l

20.21

533

927

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

589

1021

3.39

134.18

2.9

2.0

170.3

156.2

3.04

556

953

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

336

368

5.33

132.93

2.9

2.1

3107.0

50951.8

u/ml

0.45

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

407

542

4.39

130.72

1.7

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

995

2387

2.48

128.91

1.1

16.2

19.5

u/ml

0.07

(3007566) Smooth muscle Ab [Titer] in Serum

651

1237

3.10

128.78

1.3

106.2

139.0

titre

0.30

110

(3020961) Endomysium IgA Ab [Titer] in Serum

1369

3791

2.16

128.51

1.2

1.1

86.4

209.2

titre

2.52

129

(3034770) Mitochondria Ab [Titer] in Serum

636

1198

3.13

127.57

1.3

883.5

1332.1

titre

0.59

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

718

1462

2.90

126.60

2.4

1.7

186.5

204.9

pmol/l

3.32

687

1419

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1913

6039

1.92

126.25

2.4

2.1

6510.7

6798.0

u/l

0.14

761

2843

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

765

1624

2.78

125.33

2.2

1.8

—

(3047181) Lactate [Moles/volume] in Blood

481

773

3.65

121.92

7.0

2.7

1.3

1.2

mmol/l

2.73

414

687

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

332

395

4.90

120.75

3.9

1.6

67.6

26.4

mg/l

0.58

266

325

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

297

317

5.46

120.49

1.5

1.2

0.2

0.1

nmol/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

387

530

4.27

120.28

1.8

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

196

124

9.18

119.74

1.8

3.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

320

373

5.00

118.90

3.8

1.5

1.3

1.1

ratio

1.00

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

582

1085

3.15

118.61

2.1

9.5

mg/l

0.09

550

1049

(3034860) Kappa light chains.free [Mass/volume] in Serum

330

399

4.83

117.99

3.9

1.6

40.7

30.2

mg/l

2.66

263

329

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

297

324

5.34

117.96

1.5

1.2

4.0

nmol/l

0.00

286

310

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

641

1273

2.96

117.85

1.8

1.6

429.8

395.6

titre

0.07

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

277

287

5.62

115.59

1.5

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

495

851

3.41

114.04

1.9

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

272

286

5.54

111.94

1.4

1.2

—

nmol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1887

6164

1.85

111.52

4.3

2.6

30.6

32.1

6.83

1442

4384

(3004775) Volume in Urine collected for unspecified duration

131

18.06

111.02

2.2

2.0

642.1

661.8

0.11

(3039000) Anion gap in Blood

316

390

4.72

110.52

9.0

3.8

11.4

mmol/l

0.13

285

347

(3018572) Chloride [Moles/volume] in Blood

316

391

4.71

110.22

9.0

3.8

105.8

105.4

mmol/l

0.49

286

348

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

976

2512

2.30

108.33

2.1

1.6

39.3

43.0

nmol/l

3.33

955

2489

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

284

324

5.10

107.89

1.7

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

372

542

4.01

107.20

1.1

1.0

119.8

117.6

0.53

335

469

(40760888) Immunoglobulin light chains.free panel - Serum

264

282

5.45

107.03

3.9

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2731

10052

1.66

106.57

1.9

2.0

—

(4198724)

160

10.54

106.24

1.9

3.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2002

6760

1.79

106.06

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

490

884

3.25

105.02

2.9

1.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

149

11.67

104.52

1.8

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

697

1552

2.65

104.34

1.3

21.3

38.5

u/ml

1.14

101

(3025941) Bacteria identified in Stool by Culture

1332

3956

2.01

103.60

1.3

1.2

—

(4306422)

388

604

3.75

102.64

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

106

27.87

102.23

3.1

2.8

0.8

1.2

nmol/l

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

436

745

3.42

101.32

2.3

1.2

7.2

6.9

g/l

2.15

337

579

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

435

745

3.42

100.75

2.3

1.2

3.7

g/l

0.26

318

532

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

435

746

3.41

100.56

2.3

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1097

3069

2.12

99.67

2.4

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

567

1163

2.86

98.53

1.3

1.2

461.6

427.3

mg/l

1.01

546

1112

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

390

631

3.61

97.91

1.3

1.2

3.2

3.4

u/ml

0.15

187

283

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

422

722

3.42

97.88

2.6

—

(3017732) Neutrophils [#/volume] in Blood

1398

4311

1.94

97.65

2.6

1.7

4.1

4.0

e9/l

0.56

1175

3646

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

297

388

4.46

97.52

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

404

675

3.50

96.96

1.2

4.2

3.8

u/ml

0.10

142

238

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1467

4624

1.90

96.02

2.4

2.3

22.6

20.6

au/ml

0.27

504

(3016244) Insulin [Units/volume] in Serum or Plasma

287

369

4.53

95.96

2.7

3.5

31.1

24.6

mu/l

1.25

274

346

(3000034) Microalbumin [Mass/volume] in Urine

188

154

7.08

95.91

3.6

1.6

42.3

60.7

mg/l

0.41

145

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

419

724

3.38

95.79

2.4

1.2

3.0

2.8

g/l

1.19

329

570

(3003694) ABO and Rh group [Type] in Blood

5801

25693

1.44

95.73

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

573

1206

2.79

95.12

3.6

1.9

3.6

g/l

0.05

542

1140

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

182

146

7.23

94.36

9.2

4.6

11.2

9.5

mg/l

3.52

171

133

(4010399)

1166

3421

2.03

93.45

1.4

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1360

4233

1.92

92.28

1.3

42.8

47.4

au/ml

0.27

229

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

511

1028

2.91

91.80

1.3

1.2

26.1

10.1

e6/l

0.87

406

793

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

511

1029

2.91

91.65

1.4

1.2

1748.2

549.3

e6/l

0.49

426

827

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

395

678

3.40

91.19

2.4

1.2

9.8

10.3

g/l

1.89

341

580

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

389

661

3.44

91.13

1.1

1.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

845

2202

2.26

90.91

3.0

1.8

0.2

e6/l

0.12

823

2107

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

373

617

3.53

90.80

2.4

1.3

0.4

0.3

g/l

0.43

340

551

(46235355) HIV 1 and 2 tests - Meaningful Use set

5681

25277

1.42

90.10

2.1

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

1512

4916

1.84

89.74

1.3

224.7

242.2

u/ml

0.10

1398

4601

(1617658) Protocol used for examination of sentinel lymph nodes

100

21.41

89.72

1.1

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

162

119

7.89

89.62

1.6

1.4

5.0

1.6

nmol/l

1.42

138

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

504

1021

2.89

89.46

1.2

1.1

3.7

3.5

mmol/l

6.92

475

966

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

627

1441

2.56

88.16

1.3

11.5

10.5

u/ml

0.11

223

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

620

1425

2.55

87.16

1.4

1.3

6.5

8.1

u/ml

0.18

148

(3037121) Protein [Mass/volume] in Urine

571

1264

2.65

86.33

3.4

2.9

0.5

0.3

g/l

0.98

260

499

(3004809) Band form neutrophils/100 leukocytes in Blood

258

333

4.51

85.92

3.1

2.0

1.5

0.01

209

244

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

564

1252

2.64

84.81

1.3

1.2

44.3

41.2

u/ml

0.14

106

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

340

560

3.54

83.28

2.3

1.3

0.0

g/l

0.63

326

532

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

680

1676

2.38

82.73

2.1

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1285

4068

1.88

82.58

1.2

—

(3037756) Immunofixation for Serum or Plasma

222

260

4.96

82.15

1.8

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

627

1493

2.47

82.03

1.9

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

226

272

4.83

81.27

1.5

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

564

1280

2.58

81.26

1.3

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4755

20796

1.42

81.09

1.8

1.7

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

308

482

3.72

80.93

1.4

1.2

5.7

6.4

umol/l

1.88

291

452

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

211

240

5.10

80.46

1.6

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

128

9.26

78.86

2.9

1.4

168.8

116.6

umol/l

0.53

(3016879) Cocaine [Presence] in Urine

1280

4112

1.85

78.51

2.3

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

528

1180

2.62

78.36

1.5

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

282

423

3.88

78.36

1.5

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

375

688

3.18

78.30

2.4

1.9

132.6

136.4

g/l

2.34

295

520

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4969

22020

1.41

78.11

1.8

1.6

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

243

324

4.36

77.99

1.5

1.4

72.1

72.4

0.09

228

310

(1002224) Polysomnography panel

1066

3231

1.95

77.73

1.1

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

368

674

3.18

77.05

1.3

1.2

46.7

54.5

titre

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

248

340

4.24

77.04

1.4

1.1

20.4

14.0

u/l

0.67

223

294

(3044290) Cell count panel - Cerebral spinal fluid

462

970

2.78

76.99

1.4

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

533

1209

2.58

76.86

1.3

1.2

263.9

234.2

u/ml

1.40

333

766

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

238

318

4.35

76.21

1.5

1.4

573.7

519.3

mu/l

0.16

223

304

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

438

902

2.84

75.54

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

15556

83109

1.49

75.48

14.8

5.6

40.3

40.9

22.69

12078

71520

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

316

530

3.47

75.46

1.3

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

520

1177

2.59

75.29

1.4

1.2

13.9

22.4

u/ml

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

302

494

3.56

74.71

2.4

1.3

0.0

g/l

0.05

288

467

(3006653) Thiamine [Moles/volume] in Blood

150

127

6.84

74.63

1.4

1.2

133.1

132.2

nmol/l

0.07

150

127

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

300

489

3.57

74.58

2.4

1.3

0.0

g/l

0.00

288

466

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

281

437

3.74

74.48

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

400

788

2.96

74.45

1.5

1.6

0.6

0.8

g/l

2.16

287

620

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

324

560

3.37

74.07

2.3

1.3

38.3

40.2

g/l

4.71

296

495

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

460

996

2.70

72.47

1.7

1.4

8.9

8.4

iu/ml

0.04

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

252

369

3.97

72.23

1.1

1.0

94.4

94.6

0.03

238

336

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

717

1923

2.19

71.91

2.3

2.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

106

10.75

71.33

39.5

29.6

7.7

7.0

ug/l

1.57

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

488

1103

2.59

70.85

1.3

1.2

2.7

7.1

u/ml

0.69

100

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

240

344

4.05

70.66

1.6

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

361

702

3.00

68.67

3.4

2.7

285.8

83.5

u/ml

0.75

304

603

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

449

992

2.64

68.11

3.4

56.7

56.2

0.36

449

992

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

469

1060

2.59

68.10

1.3

1.2

8.4

15.2

u/ml

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

488

1127

2.53

67.90

1.4

1.2

101.8

106.7

u/ml

0.35

105

241

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

161

166

5.62

67.61

1.9

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

161

166

5.62

67.61

1.9

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

161

166

5.62

67.61

1.9

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

199

253

4.56

67.47

1.2

56.6

63.4

u/l

0.63

136

160

(4268621)

275

455

3.51

66.98

2.3

2.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

442

978

2.64

66.86

3.1

3.3

3.9

3.8

e9/l

0.47

442

978

(43055514) Macroprolactin [Presence] in Serum or Plasma

199

258

4.47

66.01

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

1351

4642

1.73

65.96

2.2

1.3

—

(3042517) Benzodiazepines panel - Urine

34.10

65.57

3.9

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

403

859

2.74

65.36

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

193

246

4.55

65.26

1.5

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

966

3004

1.90

65.14

1.3

1.2

—

(3027008) Opiates [Presence] in Urine

1361

4707

1.72

64.89

2.2

1.2

—

(3028300) Cannabinoids [Presence] in Urine

1361

4714

1.71

64.54

2.3

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

275

468

3.42

64.35

1.4

1.3

0.4

g/l

0.22

183

336

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

221

320

4.01

64.28

1.4

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

275

469

3.41

64.15

1.4

1.3

3.0

3.2

g/l

0.85

183

332

(3027135) IgG subclass 1 [Mass/volume] in Serum

275

469

3.41

64.15

1.4

1.3

7.2

6.6

g/l

1.33

182

334

(4062490)

272

469

3.37

62.45

1.4

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

261

440

3.45

61.92

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

12.96

61.46

1.9

1.1

184.5

4.1

ug/min

1.43

(3008757) Leukocyte morphology finding [Identifier] in Blood

183

236

4.49

61.10

3.9

1.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

200

279

4.16

60.92

1.8

1.4

—

(40768795) Lymph node Pathology biopsy report

144

148

5.63

60.69

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

897

2786

1.90

60.64

1.4

1.3

—

(3016038) Potassium [Moles/volume] in Urine

109

7.88

60.42

1.8

1.5

34.1

37.2

mmol/l

0.42

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

176

222

4.59

60.24

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

219

336

3.78

59.17

3.4

2.5

263.1

614.6

u/ml

0.39

206

306

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1109

3723

1.76

58.48

2.0

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

597

1628

2.15

57.42

1.2

1.1

—

(3042733) HLA Ab [Presence] in Serum

11.03

57.37

5.0

3.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

788

2400

1.93

56.38

1.6

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

784

2384

1.93

56.35

1.1

5.2

6.0

u/ml

0.19

114

428

(3027944) Amphetamines [Presence] in Urine

1320

4699

1.66

56.33

2.2

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

599

1650

2.12

56.19

1.2

1.1

—

(40768793) Breast Pathology biopsy report

331

691

2.79

55.78

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

601

1663

2.11

55.74

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3784

16788

1.37

55.64

2.1

1.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

137

148

5.36

55.10

1.8

1.6

6.8

4.6

mmol/24h

1.22

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

173

234

4.28

54.72

1.9

1.5

—

(3024471) HLA-A [Type]

10.11

54.67

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1296

4627

1.66

54.65

1.1

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

274

520

3.06

54.31

1.3

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

274

521

3.06

54.14

1.3

1.1

—

(3024932) HLA-DR beta [Type]

10.39

53.57

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

211

340

3.60

53.41

7.3

1.6

7.7

5.8

mmol/l

8.21

183

264

(3003434) Protein [Mass/volume] in Pleural fluid

110

6.56

53.05

1.6

1.4

34.1

41.6

g/l

4.44

103

(21494890) Protein electrophoresis panel - 24 hour Urine

117

114

5.93

51.82

2.6

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

357

814

2.55

51.00

1.1

1.0

—

(40768443) Skin Pathology biopsy report

719

2201

1.91

50.64

1.2

—

(44790049)

198

317

3.62

50.59

1.7

1.5

—

(44806118)

198

317

3.62

50.59

1.7

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

164

227

4.18

50.50

1.7

1.4

5.3

5.1

u/l

0.25

133

205

(3020876) Protein [Mass/time] in 24 hour Urine

131

148

5.12

50.44

1.8

2.1

0.8

1.7

g/24h

—

(44790047)

198

318

3.61

50.37

1.7

1.5

—

(44790048)

198

318

3.61

50.37

1.7

1.5

—

(40768441) Liver Pathology biopsy report

160

218

4.25

50.21

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

200

325

3.57

50.06

1.2

1.1

ratio

0.08

108

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

201

328

3.55

50.02

1.0

295.3

284.1

mg/l

0.87

172

308

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

213

363

3.40

49.83

1.1

1.0

—

(3049717) Cytology report of Urine Cyto stain

373

886

2.45

49.06

2.0

2.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

118

124

5.50

48.78

1.4

1.2

—

(3011648) Oxygen content in Venous blood

129

149

5.01

48.58

3.5

2.3

10.9

12.5

2.94

129

149

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

192

310

3.59

48.51

1.4

1.2

—

(40768446) Kidney Pathology biopsy report

6.83

48.43

1.8

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

130

152

4.95

48.35

1.6

1.5

5.5

4.8

u/l

0.15

(3022689) Creatine [Moles/volume] in Urine

9.46

48.22

1.7

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

175

267

3.80

47.72

1.5

1.2

1.3

1.5

promille

0.85

135

213

(3023199) Leukocytes [#/volume] in Pleural fluid

106

102

6.01

47.50

1.6

1.3

1853.4

4961.1

e6/l

2.50

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4105

18862

1.32

46.62

2.2

2.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

312

697

2.60

46.42

1.3

50.6

29.5

u/ml

0.74

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.55

45.82

2.7

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

237

458

3.00

45.68

1.5

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

237

459

3.00

45.51

1.5

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

237

459

3.00

45.51

1.5

1.2

—

(21494755) Public health laboratory ask at order entry panel

2151

16702

0.71

45.43

1.3

—

(3011412) CD3 cells [#/volume] in Blood

215

393

3.17

45.31

2.2

2.3

1.2

e9/l

0.32

127

197

(3003327) Ova and parasites identified in Stool by Light microscopy

782

2551

1.80

45.21

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

244

483

2.93

45.18

1.5

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

754

2437

1.81

44.91

1.3

1.2

3.4

3.5

ug/l

0.31

707

2335

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

238

466

2.96

44.89

1.5

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

6.30

44.88

1.2

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

189

320

3.42

44.69

1.2

1.1

1.9

1.7

mmol/l

2.18

177

303

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

924

3176

1.71

44.65

2.5

1.7

31.1

26.0

u/ml

0.92

893

3071

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

207

373

3.22

44.60

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3450

15544

1.34

44.51

4.1

2.8

1.5

1.9

ug/l

1.33

3126

14618

(3008116) Ketones [Moles/volume] in Urine by Test strip

15.86

44.48

1.8

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

237

469

2.93

43.92

1.5

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

7.11

43.83

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

152

224

3.93

43.39

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

169

270

3.62

43.37

2.1

2.0

—

(3004451) EKG impression Narrative

11.01

43.06

1.2

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

275

602

2.65

42.56

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

6.52

42.33

1.4

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

5.97

41.94

1.4

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

6.04

41.92

25.1

17.1

120.9

129.5

ug/l

0.39

(3008898) HLA-B27 [Presence]

972

3446

1.66

41.85

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

147

218

3.90

41.64

2.8

2.3

57.6

55.7

0.36

100

132

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

112

132

4.90

41.37

1.2

114.1

66.7

u/l

1.70

111

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

111

130

4.93

41.27

1.2

37.6

10.5

u/l

1.15

104

(3023419) Bacteria identified in Sputum by Culture

179

309

3.35

41.18

2.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

100

108

5.35

40.33

1.7

1.8

—

(3017704) Immunofixation for Urine

7.17

39.97

1.6

1.4

—

(3036603) Volume of Urine

132

186

4.10

39.87

1.7

1.5

2346.2

1884.6

1.10

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

6.29

39.74

1.4

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3970

18500

1.30

39.65

1.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

132

187

4.08

39.62

1.7

1.9

2.0

1.9

umol/l

1.32

123

180

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

223

453

2.85

39.56

1.3

1.5

—

titre

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

831

2870

1.70

39.42

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

24.21

39.04

8.5

5.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

328

820

2.32

38.74

1.4

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

152

246

3.57

38.37

1.1

1.5

5.5

nmol/l

0.72

(3045142) Bone marrow Pathology biopsy report

125

174

4.15

38.34

1.4

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

142

219

3.75

38.27

3.2

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

105

5.28

38.27

1.3

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

274

637

2.50

37.75

1.1

1.5

1.4

g/l

4.49

242

589

(3045788) Cell count panel - Pleural fluid

6.07

37.62

1.6

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

5.65

37.40

1.6

1.4

13494.7

58334.6

e6/l

0.94

(3044242) Glucose [Moles/volume] in Arterial blood

7.02

37.32

1.7

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

104

5.22

37.06

2.1

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

104

5.22

37.06

2.1

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

104

5.22

37.06

2.1

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

154

259

3.44

36.85

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

105

5.17

36.71

2.1

1.4

—

(3044927) Protein electrophoresis panel - Urine

113

150

4.35

36.68

1.4

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

23.05

36.68

8.4

5.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

112

5.00

36.64

3.1

28.2

27.7

umol/l

0.13

(3016018) Differential panel - Cerebral spinal fluid

236

519

2.64

36.28

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

199

401

2.87

35.84

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

197

395

2.89

35.79

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

199

402

2.87

35.69

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

154

265

3.36

35.66

2.4

2.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

196

393

2.89

35.61

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

13.55

35.58

7.0

2.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

135

212

3.68

35.55

1.1

96.7

93.3

0.45

106

160

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

199

403

2.86

35.54

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

104

5.11

35.52

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

196

395

2.87

35.30

1.2

1.1

—

(4094501)

397

1118

2.07

35.26

1.1

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

17.29

35.10

5.8

5.2

—

(3045414) Leukocytes [Presence] in Urine

763

2662

1.68

34.85

1.7

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

6.73

34.65

3.6

2.6

—

(3019977) pH of Arterial blood

5.70

34.34

3.1

1.5

7.4

0.69

(1175426) CD3 cells/100 lymphocytes in Blood

168

315

3.09

34.13

1.9

2.0

72.1

74.7

1.43

161

310

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

167

313

3.09

33.95

1.9

2.0

13.0

12.8

0.07

170

(40768806) Pleura Pathology biopsy report

5.38

33.77

1.7

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

126

4.54

33.74

1.2

28.1

13.3

u/l

1.18

106

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

584

1906

1.79

33.70

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

141

238

3.43

33.61

1.9

1.8

93.8

101.6

1.65

128

214

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

100

129

4.48

33.57

1.2

83.4

72.8

u/l

0.53

109

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

127

201

3.65

33.12

1.2

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

13.35

33.09

1.8

1.2

164870.3

1228576.5

nmol/l

0.82

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

147

260

3.27

32.72

1.2

19.2

6.0

u/ml

0.52

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

10.46

32.61

1.7

4.6

2.1

1.2

mmol/l

0.68

(3023410) Appearance of Cerebral spinal fluid

225

511

2.55

32.55

1.5

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

126

201

3.62

32.52

2.8

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

6.21

32.46

1.5

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

6.21

32.46

1.5

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

194

410

2.74

32.17

1.2

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

192

409

2.72

31.39

1.2

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

209

468

2.59

31.11

2.7

2.1

30.0

353.0

u/ml

0.45

201

368

(3034426) Prothrombin time (PT)

111

4.63

31.05

1.3

1.2

—

(3012441) Differential panel - Pleural fluid

5.23

30.92

1.7

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

171

345

2.87

30.81

1.1

—

(3006270) Folate [Moles/volume] in Blood

163

320

2.95

30.76

1.1

391.9

397.8

nmol/l

0.12

151

306

(3020717) Zinc [Moles/volume] in Serum or Plasma

141

253

3.22

30.73

1.5

1.4

27.1

25.6

umol/l

0.20

134

247

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

233

558

2.42

30.29

1.2

1.1

35.8

40.5

mg/l

0.86

195

460

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

225

530

2.46

30.28

1.1

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

380

1120

1.97

29.91

1.5

1.4

—

(3051651) Icteric interference index of Serum or Plasma

133

4.17

29.71

4.0

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2483

11264

1.31

29.19

2.0

1.9

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

105

159

3.81

29.10

1.7

2.0

29.1

28.3

umol/l

0.32

100

153

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

158

315

2.90

29.08

2.3

2.4

0.2

e9/l

1.07

130

257

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

118

195

3.50

29.05

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

612

2119

1.68

28.76

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

6.85

28.66

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

130

4.13

28.49

1.4

1.2

5.9

5.2

mmol/l

2.42

119

(21494815) CD4 cells/100 lymphocytes in Specimen

184

407

2.62

28.09

2.1

2.3

41.5

46.6

0.77

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

186

3.51

27.99

1.1

1.0

—

(3003338) MCHC [Mass/volume]

14274

77970

1.23

27.89

17.9

6.2

333.0

334.0

g/l

32.14

14191

77217

(3047189) Immunofixation for 24 hour Urine

6.89

27.81

2.1

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

8.07

27.80

1.7

1.4

97.8

42.4

mu/l

1.51

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

158

324

2.82

27.72

2.3

2.4

522.4

511.6

e6/l

0.10

128

258

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

223

546

2.37

27.70

1.1

1.0

227.4

218.7

mg/l

0.27

192

486

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

118

202

3.37

27.64

1.7

1.4

—

(3000492) Spirometry study

1781

7758

1.35

27.55

1.4

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

178

392

2.63

27.42

1.1

1.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

132

247

3.09

27.01

1.2

1.1

68.6

91.0

1.67

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

161

339

2.75

26.96

1.2

17.8

6.9

u/ml

0.45

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

9.68

26.76

4.1

4.6

40.4

13.6

ug/min

2.69

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

154

318

2.80

26.71

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

142

280

2.93

26.67

3.6

1.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

253

669

2.19

26.41

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

163

352

2.68

26.08

1.2

38.8

57.9

u/ml

0.37

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

154

323

2.76

25.99

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

119

214

3.21

25.93

1.2

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

159

340

2.70

25.91

2.5

797.6

879.2

e6/l

0.57

139

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

163

354

2.66

25.81

1.2

60.1

29.9

u/ml

0.66

(3038026) Centromere Ab [Units/volume] in Serum

165

361

2.64

25.77

1.2

46.2

19.9

u/ml

0.59

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

226

577

2.27

25.62

1.1

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

634

2288

1.61

25.42

1.7

1.6

27.8

0.5

iu/ml

0.49

120

416

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1854

13611

0.76

25.28

1.7

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

103

172

3.46

25.05

1.1

—

(3000012) Reticulocyte production index

100

4.39

25.05

1.5

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

123

3.99

25.02

13.9

1.2

2220.5

16577.5

mg/l

1.58

(3017569) Oxygen content in Arterial blood

5.49

24.99

1.9

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.84

24.99

1.4

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.84

24.99

1.4

1.1

—

(3000330) Specific gravity of Urine by Test strip

614

2219

1.61

24.49

2.9

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.93

24.36

2.4

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.93

24.36

2.4

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

113

205

3.18

24.32

1.6

1.5

1212300.0

374562.8

iu/ml

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

167

380

2.54

24.21

1.3

167.7

158.0

titre

0.06

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

167

380

2.54

24.21

1.3

95.0

270.0

titre

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

8.44

23.99

1.8

1.2

13.1

10.3

g/l

0.60

(1761482) Bacteria [#/volume] in Urine by Culture

284

817

2.01

23.98

3.2

2.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

166

3.44

23.96

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

651

2400

1.58

23.92

1.4

1.3

—

(4027681)

186

449

2.40

23.89

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

8.07

23.85

2.6

1.6

1020.9

1396.4

e6/l

0.15

(3045424) Erythrocytes [Presence] in Urine

333

1018

1.90

23.68

1.5

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1952

8804

1.31

23.60

1.8

1.7

—

(21494434) Karyotype in Bone marrow

143

3.63

23.48

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

6.27

23.44

1.2

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.55

23.04

1.8

1.2

3103.5

2257.2

u/ml

—

(3023420) DNA double strand Ab [Units/volume] in Serum

239

658

2.10

22.67

1.8

1.6

27.2

35.5

iu/ml

0.32

(3000475) Leukocytes [#/volume] in Synovial fluid

329

1018

1.87

22.59

1.7

1.6

10166.0

10103.5

e6/l

0.01

252

754

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

22.40

1.6

0.0

509.3

—

nmol/l

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

+∞

22.40

8.1

0.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.48

22.33

2.4

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

113

3.93

22.31

1.9

2.4

13.5

47.7

umol/l

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

143

314

2.63

22.25

1.5

1.6

—

(3035880) pH of Pleural fluid

6.65

22.17

1.3

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.43

22.04

1.9

1.8

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

163

385

2.45

21.96

1.1

1.0

u/l

0.51

159

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

8.11

21.67

1.2

1.3

39.0

48.2

ng/l

0.18

(3029634) Reagin Ab [Titer] in Serum by VDRL

358

1154

1.80

21.64

1.8

1.9

10.1

8.3

titre

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

149

340

2.53

21.54

1.3

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

8.64

21.41

1.1

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

5.76

21.39

1.5

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

6.33

21.29

7.5

1.5

43.4

106.6

u/l

0.45

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

8.20

21.26

2.2

1.4

2500.2

15806.1

e6/l

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

292

889

1.90

21.08

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

7.49

21.04

1.2

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1264

9559

0.74

21.04

1.4

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

7.20

20.97

1.4

1.2

333.5

279.1

pmol/l

0.56

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

170

3.23

20.95

2.5

53.5

52.7

umol/l

0.09

159

(3010370) Gastrin [Moles/volume] in Serum or Plasma

6.03

20.89

2.0

1.5

33.4

28.1

pmol/l

0.15

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

100

186

3.10

20.77

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

122

256

2.75

20.68

2.0

127.0

110.2

1.74

115

248

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

953

3919

1.42

20.68

1.9

1.3

4.0

2.7

mg/l

4.33

731

2265

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

190

495

2.22

20.66

1.4

1.3

1.2

1.5

u/ml

0.13

179

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

183

470

2.25

20.57

2.0

1.6

28.2

26.2

mg/l

0.16

120

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.34

20.33

3.9

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.34

20.33

3.9

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

171

3.17

20.23

1.0

40.2

42.5

ng/l

0.15

131

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

9.92

20.05

1.0

60.0

32.7

mg/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

172

3.15

20.05

1.0

296.8

316.9

ng/l

0.22

136

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

172

3.15

20.05

1.0

849.7

709.5

ng/l

1.43

127

(40765096) Chromosome analysis panel by Banding

6.56

20.01

1.0

1.1

—

(4034850)

515

1878

1.59

19.86

10.6

4.1

—

(3022621) pH of Urine by Test strip

963

4008

1.40

19.52

2.7

2.1

—

(3014271) Vancomycin [Susceptibility]

4.98

19.39

2.4

1.8

—

(1761868) Lipid panel - Serum or Plasma

6837

35667

1.16

19.04

2.8

1.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

13231

72537

1.17

18.91

3.8

3.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1201

5210

1.35

18.88

1.4

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

376

1282

1.70

18.82

1.1

—

(44813793)

194

531

2.11

18.77

1.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.82

18.74

1.3

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

6.42

18.71

2.0

3.3

—

11.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

451

1616

1.62

18.70

1.6

1.4

83.5

55.4

pmol/l

1.98

435

1574

(3016273) Islet cell 512 Ab [Units/volume] in Serum

20.47

18.61

1.1

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

32.25

18.19

10.1

7.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

133

317

2.42

17.69

1.4

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.62

17.55

1.7

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

148

3.16

17.38

2.0

2.1

181.7

193.4

e6/l

0.10

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

104

221

2.72

17.31

1.1

1.2

0.3

g/l

0.56

176

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

106

228

2.68

17.26

2.7

2.9

42.9

42.5

0.04

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

198

567

2.02

17.08

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.71

17.03

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3692

18461

1.19

16.94

1.8

1.7

—

(3045716) Anion gap in Serum or Plasma

3.78

16.93

1.9

2.1

9.7

8.9

mmol/l

0.43

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

129

3.26

16.50

1.2

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

202

2.74

16.30

1.3

1.1

—

(3033799) Differential panel - Peritoneal fluid

7.51

16.25

2.7

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

420

1532

1.59

16.25

1.1

3.1

3.4

u/ml

0.22

226

938

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

930

3969

1.37

16.23

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

155

412

2.17

16.19

1.7

1.5

38.8

41.2

0.28

271

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

6.55

16.12

1.3

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

191

2.78

16.01

1.4

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

120

3.32

15.99

1.7

1.6

0.2

0.3

nmol/l

1.73

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

300

1007

1.73

15.95

2.5

2.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

208

2.69

15.92

1.1

1.2

111.0

106.1

0.98

184

(3021788) Differential panel - Synovial fluid

258

830

1.80

15.84

1.7

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

148

3.04

15.81

1.2

1.3

71.3

113.7

titre

—

(21494814) CD8 cells/100 lymphocytes in Specimen

142

3.09

15.79

1.9

2.0

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

11.04

15.77

1.1

1.0

—

mmol/l

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

6.87

15.72

2.4

1.2

6.5

5.7

mmol/l

0.63

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

106

240

2.55

15.70

3.4

4.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.62

15.48

1.1

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

189

553

1.98

15.43

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

136

350

2.24

15.36

1.2

1.6

6.0

8.2

ug/l

0.86

120

312

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

273

902

1.75

15.35

1.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

5.93

15.30

2.4

1.9

46.5

49.7

pmol/l

0.13

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

180

2.79

15.25

1.4

1.5

12.7

20.3

u/ml

1.53

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

116

280

2.39

15.10

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

185

2.74

15.00

1.2

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

+∞

14.93

1.2

0.0

55.0

—

nmol/l

—

(3044007) Cell count panel - Peritoneal fluid

6.96

14.86

1.8

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

196

2.68

14.85

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

559

2219

1.46

14.70

2.1

2.4

5.3

umol/l

0.01

400

1649

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.47

14.64

1.4

1.1

131.9

110.7

nmol/l

0.48

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.47

14.64

2.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

497

1929

1.50

14.62

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

102

3.39

14.41

1.4

1.2

17.7

16.5

umol/l

0.58

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

375

1372

1.58

14.38

1.2

1.1

17.0

10.9

au/ml

0.58

119

(3001556) Androgen free Index in Serum or Plasma

120

3.17

14.35

1.4

1.1

—

(44806071)

4.04

14.25

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

484

1879

1.49

14.23

1.5

1.4

—

(3044941) Cell count panel - Synovial fluid

210

657

1.85

14.14

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.98

14.00

1.3

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.58

13.99

1.1

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

138

2.97

13.89

1.2

1.1

14.0

9.4

0.23

(3035320) C reactive protein [Mass/volume] in Body fluid

140

381

2.12

13.88

3.0

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.02

13.85

1.5

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2618

12916

1.19

13.68

3.7

2.7

22.6

22.4

0.31

986

4641

(3033923) Metanephrine [Moles/time] in 24 hour Urine

5.76

13.61

1.1

0.7

umol/24h

0.21

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

287

1000

1.66

13.40

1.6

1.8

5050.0

3858.7

titre

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.33

13.12

1.1

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

6.81

13.11

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

10.94

12.95

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.69

12.60

2.1

1.8

—

(3026726) Creatinine [Moles/volume] in Specimen

8.64

12.51

3.0

1.4

503.4

692.5

umol/l

0.22

(3005082) Progesterone [Moles/volume] in Serum or Plasma

304

1097

1.60

12.41

1.4

1.3

28.6

34.2

nmol/l

2.93

277

1042

(3047007) Chlamydophila sp Ab [Presence] in Serum

343

1275

1.56

12.37

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

5.57

12.36

2.9

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

336

1244

1.56

12.33

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

348

1299

1.55

12.32

1.2

—

(3028433) Virus identified in Specimen by Culture

133

2.86

12.20

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

180

2.56

12.11

1.3

1.2

106.3

113.7

0.67

162

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

106

3.10

12.03

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

131

2.86

12.02

1.5

1.7

9.6

8.3

ug/l

1.25

131

(3006442) Creatine [Moles/volume] in Serum or Plasma

143

417

1.98

11.91

1.7

1.2

63.4

70.8

umol/l

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

6.26

11.80

5.2

2.2

36.8

49.3

umol/l

0.96

(3020491) Glucose [Moles/volume] in Blood

158

479

1.90

11.79

1.8

1.3

6.4

5.2

mmol/l

3.75

110

384

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

181

574

1.82

11.77

1.8

1.6

48.2

47.0

0.12

109

401

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

108

3.04

11.69

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

248

2.28

11.62

1.9

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

144

425

1.96

11.61

1.1

1.0

1525.2

1358.6

miu/ml

0.90

144

425

(3017315) Amylase [Enzymatic activity/volume] in Urine

223

2.35

11.59

1.2

296.7

353.3

u/l

0.16

214

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

174

2.55

11.57

1.1

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

151

2.67

11.50

1.1

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

5.55

11.49

1.7

1.3

24.8

19.1

g/l

0.70

(40768800) Prostate Pathology biopsy report

132

381

2.00

11.33

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

143

2.70

11.23

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

963

4358

1.29

11.22

1.3

238.1

231.4

miu/ml

0.22

480

2310

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

178

2.49

11.09

1.2

1.1

90.0

96.6

0.88

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.54

11.06

1.3

1.4

—

(3024263) Appearance of Synovial fluid

207

2.37

10.99

2.4

2.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

7.11

10.96

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

174

2.49

10.74

1.3

1.1

89.0

99.8

1.30

(3024869) Neuronal Ab [Presence] in Serum

4.03

10.66

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

123

2.76

10.35

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

835

3752

1.29

10.30

1.4

—

(3017509) Phencyclidine [Presence] in Urine

3.11

10.23

1.6

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

176

579

1.76

10.22

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.97

10.11

4.3

4.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

6.03

10.09

1.4

36.0

193.4

ug/l

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

6.77

10.07

1.1

1.2

1.6

2.8

mmol/l

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

19.56

10.01

2.8

3.0

1.4

2.4

mu/l

—

(3032057) Clostridioides difficile [Presence] in Stool

4.15

9.80

2.0

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

197

2.31

9.76

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

101

281

2.07

9.63

3.1

1.3

22.5

771.3

ug/l

1.29

268

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.96

9.59

2.0

1.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.28

9.51

1.1

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

253

939

1.56

9.31

1.6

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

129

398

1.87

9.25

1.4

66946.3

38911.5

e6/l

0.26

268

(3042010) Triglyceride [Moles/volume] in Pleural fluid

7.53

9.24

1.2

1.9

5.1

mmol/l

—

(3036180) Methadone [Presence] in Urine

+∞

9.12

3.2

0.0

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

+∞

9.12

4.1

0.0

1.6

—

g/l

—

(3048879) Bone marrow aspiration report

4.64

8.97

2.3

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

141

2.49

8.87

1.5

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.76

8.82

1.3

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

121

2.62

8.81

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

149

2.44

8.75

2.8

2.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

350

1409

1.44

8.74

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

126

2.56

8.60

1.3

1.1

—

(4281824)

132

422

1.80

8.51

1.2

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

687

4993

0.78

8.39

1.9

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

7.85

8.39

4.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

5.76

8.38

4.4

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

118

366

1.86

8.37

1.1

6.4

15.2

u/ml

2.19

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

204

2.18

8.35

1.1

103.7

264.5

ng/l

0.61

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

257

2.02

8.09

1.2

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

8.06

7.96

1.6

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

109

2.59

7.73

1.3

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

260

1017

1.48

7.60

1.4

1.5

12.8

7.8

mmol/l

3.76

(3014051) Protein [Presence] in Urine by Test strip

319

1298

1.42

7.59

2.0

1.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

5.45

7.58

1.2

1.1

1.6

1.3

umol/24h

0.95

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.89

7.37

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

126

2.42

7.35

2.8

1.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.69

7.31

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.69

7.31

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.69

7.31

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.69

7.31

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

276

1.92

7.27

1.1

1.3

—

(4024509)

134

453

1.71

7.23

1.6

1.3

—

(3002619) Bacteria identified in Specimen by Culture

2.78

7.19

1.2

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

5.44

7.14

1.6

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

157

556

1.63

7.13

1.1

7.3

iu/ml

0.01

167

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.34

6.99

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.12

6.98

1.1

1.2

—

(3019174) dRVVT (LA screen)

3.26

6.98

1.3

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

238

1965

0.69

6.97

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

225

2.00

6.89

1.8

1.5

4.9

6.0

0.18

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

108

350

1.78

6.76

1.8

1.7

2.3

2.2

u/field

0.06

175

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

4.56

6.72

1.0

20.7

10.5

u/l

0.32

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.48

6.65

2.3

1.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.08

6.63

1.3

124.0

77.6

ng/l

1.13

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

269

1.89

6.62

1.6

1.5

2.8

3.2

u/field

0.14

195

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

101

2.51

6.59

1.1

80.3

100.6

0.92

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

6.80

6.56

1.3

1.0

—

(3007463) Buprenorphine [Presence] in Urine

13.81

6.48

4.4

4.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

376

1617

1.34

6.48

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.64

6.45

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.22

6.43

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

113

2.40

6.42

1.3

42.2

51.8

0.82

(44806420)

5.12

6.36

2.1

2.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

150

543

1.59

6.30

1.4

1.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

8.95

6.28

2.4

5.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

145

521

1.61

6.28

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

3.09

6.26

1.3

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.53

6.12

2.0

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.45

6.10

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

169

2.08

6.04

1.1

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

320

1358

1.36

6.04

3.6

2.3

24.2

25.6

mg/l

0.28

189

813

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

173

2.06

6.03

1.1

1.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

4.32

6.02

1.5

1.1

1.2

5.3

ml/s/173m2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

181

693

1.51

5.97

1.5

1.6

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

170

2.07

5.96

1.1

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

170

2.07

5.96

1.1

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

399

0.39

5.94

6.3

6.9

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

399

0.39

5.94

3.1

3.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.48

5.92

1.1

43.1

80.1

2.15

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.45

5.88

1.7

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

5.81

1.3

0.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

5.81

3.1

0.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

12.66

5.80

4.1

4.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

12.66

5.80

1.0

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.88

5.80

1.9

1.6

1.2

1.8

mg/l

0.47

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

145

2.15

5.80

1.1

—

(4015189)

2.75

5.73

2.1

1.6

—

(3025577) Chromium [Mass/volume] in Blood

181

2.01

5.70

1.9

2.2

2.1

2.8

ug/l

0.64

159

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

6.28

5.69

1.8

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.91

5.67

2.2

—

(3026470) Cobalt [Mass/volume] in Blood

186

1.98

5.62

1.8

2.1

2.3

3.0

ug/l

0.78

170

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

103

2.35

5.55

1.2

1.1

65.1

87.7

0.89

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.83

5.46

1.9

1.6

0.8

2.1

mg/l

1.20

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.83

5.46

1.9

1.6

1.2

1.8

mg/l

0.40

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.83

5.46

1.9

1.6

0.5

1.2

mg/l

1.32

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.83

5.46

1.9

1.6

0.8

1.2

mg/l

0.30

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.83

5.46

1.9

1.6

1.8

4.1

mg/l

1.11

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.83

5.46

1.9

1.6

1.8

3.4

mg/l

0.66

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.83

5.46

1.9

1.6

0.9

3.8

mg/l

2.34

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.83

5.46

1.9

1.6

1.9

mg/l

0.01

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.83

5.46

1.9

1.6

2.8

5.5

mg/l

1.11

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

4.54

5.31

1.8

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.47

5.29

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

136

2.12

5.24

2.6

1.5

105.3

94.5

ng/l

0.18

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.70

5.22

1.5

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.19

5.19

1.0

—

(3013466) aPTT in Blood by Coagulation assay

3.36

5.16

1.1

36.2

36.4

0.08

(3024316) Viscosity of Plasma

11.51

5.13

1.0

1.3

—

mpas

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.67

5.06

2.6

4.3

—

(3025315) Body weight

4.32

5.03

4.1

1.2

—

(3008717) Parietal cell Ab [Titer] in Serum

+∞

4.98

1.2

0.0

1411.7

—

titre

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

+∞

4.98

1.0

0.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

147

562

1.51

4.96

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

110

2.20

4.84

1.1

0.0

0.1

u/ml

0.57

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.42

4.82

1.2

1.1

0.7

31.5

mg/l

0.49

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.29

4.79

1.1

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

542

2555

1.23

4.65

1.1

1.8

u/ml

0.04

212

1081

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

352

1578

1.29

4.65

1.4

1.5

7.1

6.2

mmol/l

5.54

252

1096

(3022475) Manganese [Moles/volume] in Blood

3.62

4.65

1.4

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.02

4.63

1.1

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

492

2298

1.24

4.61

1.1

5.6

6.3

u/ml

0.39

262

1284

(3020393) Adenovirus Ag [Presence] in Stool

2.82

4.54

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.92

4.53

2.7

2.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.94

4.47

1.1

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.68

4.47

1.2

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

428

1976

1.25

4.46

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.40

4.46

1.5

1.0

—

(3020650) Glucose [Presence] in Urine

228

1.77

4.46

1.4

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

427

1978

1.25

4.34

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

297

1.65

4.25

1.1

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.21

4.22

1.5

1.2

37.1

43.0

g/l

1.27

(4212803)

8.63

4.14

1.0

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.84

4.12

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1863

9741

1.11

4.10

2.7

2.2

0.6

0.7

ug/l

3.74

1088

4564

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.88

3.94

1.8

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

125

1.98

3.89

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.05

3.89

1.1

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.56

3.86

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

150

1.88

3.84

1.2

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.64

3.75

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

2.41

3.74

1.8

1.6

11.5

1.6

ug/l

0.46

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

164

1.83

3.73

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.58

3.62

1.6

1.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.14

3.56

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.84

3.54

1.0

0.0

u/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

460

2199

1.21

3.54

1.1

1.0

1.1

u/ml

0.08

194

1003

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.43

3.46

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.43

3.46

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

135

1.88

3.46

1.3

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

128

516

1.43

3.45

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

136

1.86

3.39

2.8

2.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.96

3.37

4.7

2.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.17

3.33

1.3

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.41

3.32

2.0

1.6

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.58

3.25

3.0

6.7

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

8.05

3.21

1.0

—

(46236302) HLA-C [Type] by High resolution typing

8.05

3.21

1.1

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

2.88

3.19

1.0

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2734

14725

1.08

3.16

1.5

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

136

1.82

3.12

1.1

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

5.18

3.12

1.6

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.45

3.12

1.0

0.0

u/ml

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

5.75

3.01

2.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

5.75

3.01

1.3

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

5.75

3.01

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

5.75

3.01

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

5.75

3.01

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

5.75

3.01

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

5.75

3.01

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

5.75

3.01

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.09

2.99

1.3

1.2

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.84

2.96

1.3

1.0

35.8

35.3

—

(3049233) Organic acids panel - Urine

6.71

2.93

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

5.11

2.80

1.1

1.0

117.2

124.9

mmol/24h

—

(40757373) Influenza virus identified in Isolate

2.24

2.65

1.3

1.6

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.88

2.61

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

6.90

2.60

1.0

—

(40763590) HLA-DQ beta [Type]

6.90

2.60

1.2

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

183

821

1.28

2.59

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.62

2.57

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.26

2.57

1.2

1.4

17.7

15.3

nmol/l

—

(3015183) Erythrocyte sedimentation rate

132

568

1.34

2.52

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

193

877

1.27

2.48

1.4

1.3

379.7

78.4

pmol/l

0.53

166

(3052592) Norovirus Ag [Presence] in Stool

2.39

2.46

1.5

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.90

2.44

1.4

1.3

—

(3001729) Color of Synovial fluid

2.88

2.42

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.70

2.41

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.70

2.41

1.3

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.45

2.27

1.7

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

139

614

1.30

2.26

1.4

1.5

5.4

5.0

mmol/l

3.43

128

593

(3025130) Human papilloma virus identified in Specimen

346

1691

1.18

2.23

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

320

1.42

2.21

1.1

0.5

18.0

u/ml

1.67

200

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.40

2.21

1.1

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

496

3251

0.87

2.20

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

113

1.73

2.19

1.4

1.5

40.6

43.9

0.18

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

140

623

1.29

2.17

1.8

1.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

175

802

1.26

2.15

1.1

0.5

4.8

u/ml

1.10

220

(3013862) HLA-DP [Type]

4.93

2.15

1.2

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.92

2.12

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

348

1.39

2.09

1.2

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.25

2.07

1.1

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

229

1.48

2.07

1.1

0.5

12.1

u/ml

1.89

164

(3016031) Almond IgE Ab [Units/volume] in Serum

1.85

2.07

1.1

1.0

0.1

1.0

u/ml

2.97

(3047352) Trisomy 18 risk [Likelihood] in Fetus

820

5196

0.90

2.06

1.5

—

(3005033) Fetal Nuchal fold Thickness US

818

5183

0.90

2.06

1.4

1.5

—

(4211845)

325

1.40

2.05

2.6

2.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

180

1.54

1.98

1.2

1.3

0.1

12.3

u/ml

0.92

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.29

1.98

3.0

2.6

42.1

44.9

umol/l

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

104

451

1.33

1.97

1.9

2.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.66

1.96

1.3

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.66

1.96

7.0

1.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.95

1.7

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

113

1.68

1.95

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

295

1.41

1.93

2.7

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

839

5290

0.91

1.93

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.21

1.90

1.1

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.88

1.89

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

367

1831

1.16

1.88

1.1

6.4

5.5

u/ml

0.22

143

791

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.99

1.87

1.2

1.8

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

128

1.62

1.86

1.1

1.0

0.0

1.0

u/ml

1.09

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

156

721

1.25

1.84

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.84

1.83

1.0

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.84

1.83

1.1

1.4

—

(3018291) Platelet Ab [Presence] in Serum

4.79

1.82

1.4

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.89

1.80

1.7

1.4

0.4

ug/l

0.12

(3036071) Salmonella sp Ab [Titer] in Serum

281

1.39

1.77

1.0

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

2.27

1.74

1.3

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

389

1963

1.14

1.73

1.1

3.6

5.4

u/ml

1.17

149

805

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

131

1.58

1.72

1.1

1.0

0.0

4.3

u/ml

0.77

(40762814) Titanium [Mass/volume] in Blood

1.95

1.71

2.1

2.5

3.3

7.3

ug/l

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.43

1.70

1.4

1.0

2.5

0.3

umol/24h

—

(3040893) Potassium [Moles/volume] in Capillary blood

4.11

1.64

2.6

2.3

4.4

4.2

mmol/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.70

1.64

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

261

1.39

1.64

2.4

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

444

2270

1.13

1.63

1.1

1.6

2.7

u/ml

0.99

109

597

(3041672) Baker's yeast Ab [Presence] in Serum

2.05

1.62

1.0

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

111

1.61

1.60

11.1

2.9

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.34

1.58

1.2

1.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.85

1.57

1.1

1.2

11.4

28.2

u/ml

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

172

820

1.21

1.56

1.0

1.1

3.2

3.9

u/ml

0.10

199

(3009015) Lactate [Moles/volume] in Synovial fluid

2.23

1.56

1.3

7.0

mmol/l

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

122

1.56

1.51

1.1

1.0

0.1

0.5

u/ml

0.97

(3041806) Other cells [#/volume] in Blood by Manual count

153

724

1.22

1.51

1.6

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

174

1.46

1.49

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

189

1.43

1.47

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

2.68

1.46

1.6

1.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

129

1.52

1.41

1.0

0.0

0.3

u/ml

1.66

(3016135) IgD [Mass/volume] in Serum

2.88

1.40

1.2

27.0

70.3

mg/l

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.88

1.40

1.2

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.88

1.40

1.3

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.92

1.38

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

313

1588

1.14

1.36

1.1

1.0

0.7

0.4

u/ml

0.22

314

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.20

1.35

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.20

1.35

1.0

1.8

3.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

393

1.27

1.32

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

120

563

1.23

1.32

1.3

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

161

779

1.19

1.30

1.0

0.3

1.4

u/ml

0.85

102

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

2.16

1.29

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

2.16

1.29

4.2

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.11

1.29

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.69

1.28

3.4

1.5

25.5

2.8

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.59

1.23

1.1

3.9

12.3

u/ml

1.86

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

1.21

0.0

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

131

629

1.20

1.18

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.83

1.16

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

112

1.49

1.15

1.8

1.4

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.09

1.13

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1047

6383

0.94

1.13

1.4

1.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.67

1.12

1.1

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

2.37

1.12

1.9

1.2

2.3

3.7

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.61

1.12

2.8

1.9

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1042

6350

0.94

1.11

1.4

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

388

1.25

1.11

1.1

1.0

6.5

12.0

u/ml

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1047

6378

0.94

1.11

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1046

6367

0.94

1.08

1.4

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.98

1.03

1.0

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.58

1.02

1.0

0.2

4.9

u/ml

1.43

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.47

0.98

1.2

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.85

0.97

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.47

0.96

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.92

0.95

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

891

4839

1.06

0.95

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

224

0.72

0.93

1.9

1.8

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

2.16

0.90

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.86

0.88

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

105

1.42

0.87

1.1

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.52

0.83

1.3

1.7

0.5

0.7

u/field

0.58

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

360

2247

0.92

0.81

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1135

6820

0.95

0.79

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

158

1.31

0.77

1.3

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

372

1.19

0.74

5.6

6.5

1178.3

9476.4

u/ml

0.53

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.83

0.73

1.0

—

2.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.05

0.73

1.2

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

290

1814

0.92

0.72

1.6

1.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

126

1.32

0.68

1.0

1.1

0.0

2.6

u/ml

1.95

100

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.80

0.65

1.0

1.8

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

201

1.23

0.60

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

1.37

0.59

1.2

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.46

0.57

1.1

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

120

618

1.12

0.54

2.8

3.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

439

0.86

0.53

3.3

3.5

7.0

8.7

mg/l

1.61

361

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1109

6183

1.03

0.48

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.31

0.47

5.0

3.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2185

12318

1.02

0.44

1.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.60

0.43

1.2

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.43

0.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

623

0.90

0.42

1.4

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.64

0.37

1.2

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

121

0.81

0.32

1.4

1.1

6.8

5.5

mmol/l

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

131

1.19

0.31

1.0

1.1

0.0

3.1

u/ml

2.17

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.26

0.30

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1040

5872

1.02

0.23

1.8

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.27

0.22

1.5

1.2

323.5

301.0

umol/24h

0.11

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

1.1

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.22

0.0

1.2

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.21

0.0

1.0

—

162.5

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.21

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.82

0.21

1.3

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.28

0.21

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1406

8199

0.99

0.20

1.5

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

319

1885

0.97

0.17

1.5

1.6

7.7

7.2

mmol/l

2.87

209

1078

(3009677) Dengue virus Ab [Presence] in Serum

1.18

0.16

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

332

1864

1.02

0.15

3.2

1.7

13.1

13.0

0.59

326

1833

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

400

0.95

0.13

2.9

125.4

116.4

au/ml

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.12

0.11

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.17

0.11

1.1

8.9

8.4

mmol/l

—

(4133840)

301

1.05

0.10

1.3

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.15

0.10

1.2

—

(3022670) pH of Venous cord blood

1.09

0.08

1.1

1.0

—

(4038314)

101

1.08

0.07

1.2

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

1.06

0.07

5.0

6.6

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

105

1.04

0.01

1.1

1.0

0.1

1.2

u/ml

0.70

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

372

0.99

0.00

1.9

2.0

9.9

10.3

mg/l

0.25

304

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.96

0.00

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.05

0.00

1.7

1.3

1.5

1.6

mg/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

128

736

1.00

0.00

1.4

1.2

1.3

1.5

g/l

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

555

1.01

0.00

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

118

0.97

0.00

2.3

2.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.00

0.00

1.0

1.1

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: HYPOTHY_LEVOTHY – Hypothyroidism, levothyroxine purchases

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hypothyroidism, levothyroxine purchases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Case counts by code for Hypothyroidism, levothyroxine purchases (HYPOTHY_LEVOTHY)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints